Takeda Pharmaceuticals U.S.A., Inc. v. Hikma Pharmaceuticals USA, Inc.
1:14-cv-01268
Overview
Case Number
1:14-cv-01268
Filing Date
2014-10-03
Status
Litigation filed
Court
District Court, D. Delaware
Nature of Suit
830 Patent
Parties
Defendant
Plaintiff
Court & Judges
Court
District Court, D. Delaware
Presiding Judge
Richard Gibson Andrews
Patents Involved
No asserted patent numbers detected in initial docket filings yet.
Docket Entries
COMPLAINT FOR DECLARATORY JUDGMENT OF PATENT INFRINGEMENT filed against Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1600907.) - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Civil Cover Sheet)(dmp, ) (Entered: 10/03/2014)
2014-10-03
1
COMPLAINT FOR DECLARATORY JUDGMENT OF PATENT INFRINGEMENT filed against Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1600907.) - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Civil Cover Sheet)(dmp, ) (Entered: 10/03/2014)
2014-10-03
2
COMPLAINT FOR DECLARATORY JUDGMENT OF PATENT INFRINGEMENT filed against Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1600907.) - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Civil Cover Sheet)(dmp, ) (Entered: 10/03/2014)
2014-10-03
2
COMPLAINT FOR DECLARATORY JUDGMENT OF PATENT INFRINGEMENT filed against Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1600907.) - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Civil Cover Sheet)(dmp, ) (Entered: 10/03/2014)
2014-10-03
2
COMPLAINT FOR DECLARATORY JUDGMENT OF PATENT INFRINGEMENT filed against Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1600907.) - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Civil Cover Sheet)(dmp, ) (Entered: 10/03/2014)
2014-10-03
2
COMPLAINT FOR DECLARATORY JUDGMENT OF PATENT INFRINGEMENT filed against Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1600907.) - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Civil Cover Sheet)(dmp, ) (Entered: 10/03/2014)
2014-10-03
2
COMPLAINT FOR DECLARATORY JUDGMENT OF PATENT INFRINGEMENT filed against Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1600907.) - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Civil Cover Sheet)(dmp, ) (Entered: 10/03/2014)
2014-10-03
2
COMPLAINT FOR DECLARATORY JUDGMENT OF PATENT INFRINGEMENT filed against Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1600907.) - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Civil Cover Sheet)(dmp, ) (Entered: 10/03/2014)
2014-10-03
2
COMPLAINT FOR DECLARATORY JUDGMENT OF PATENT INFRINGEMENT filed against Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1600907.) - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Civil Cover Sheet)(dmp, ) (Entered: 10/03/2014)
2014-10-03
2
COMPLAINT FOR DECLARATORY JUDGMENT OF PATENT INFRINGEMENT filed against Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1600907.) - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Civil Cover Sheet)(dmp, ) (Entered: 10/03/2014)
2014-10-03
2
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (dmp, ) (Entered: 10/03/2014)
2014-10-03
1
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,964,647; US 7,964,648; US 7,981,938; US 8,097,655; US 8,440,722;. (dmp, ) (Entered: 10/03/2014)
2014-10-03
1
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Takeda American Holdings Inc., Other Affiliate Takeda Pharmaceutical Company Limited for Takeda Pharmaceuticals U.S.A., Inc. filed by Takeda Pharmaceuticals U.S.A., Inc.. (dmp, ) (Entered: 10/03/2014)
2014-10-03
1
Summons Issued with Magistrate Consent Notice attached as to Hikma Americas Inc. on 10/3/2014; Hikma Pharmaceuticals PLC on 10/3/2014; West-Ward Pharmaceutical Corporation on 10/3/2014. (dmp, )
2014-10-03
1
No Actions
MOTION for Temporary Restraining Order and Preliminary Injunction - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Text of Proposed Order Exhibit A, # 2 Text of Proposed Order Exhibit B)(Bourke, Mary) (Entered: 10/06/2014)
2014-10-06
1
[SEALED] OPENING BRIEF in Support re 5 MOTION for Temporary Restraining Order and Preliminary Injunction filed by Takeda Pharmaceuticals U.S.A., Inc..Answering Brief/Response due date per Local Rules is 10/23/2014. (Bourke, Mary) (Entered: 10/06/2014)
2014-10-06
1
DECLARATION re 5 MOTION for Temporary Restraining Order and Preliminary Injunction Declaration of Chad S. Boomershine by Takeda Pharmaceuticals U.S.A., Inc.. (Bourke, Mary) (Entered: 10/06/2014)
2014-10-06
1
[SEALED] DECLARATION re 5 MOTION for Temporary Restraining Order and Preliminary Injunction Declaration of Matthew W. Woods by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit A)(Bourke, Mary) (Entered: 10/06/2014)
2014-10-06
1
[SEALED] DECLARATION re 5 MOTION for Temporary Restraining Order and Preliminary Injunction Declaration of Mary W. Bourke by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V)(Bourke, Mary) (Entered: 10/06/2014)
2014-10-06
1
NOTICE of Appearance by Dominick T. Gattuso on behalf of Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation (Gattuso, Dominick) (Entered: 10/06/2014)
2014-10-06
1
SUMMONS Returned Executed by Takeda Pharmaceuticals U.S.A., Inc.. West-Ward Pharmaceutical Corporation served on 10/3/2014, answer due 10/24/2014. (Bourke, Mary) (Entered: 10/06/2014)
2014-10-06
1
SUMMONS Returned Executed by Takeda Pharmaceuticals U.S.A., Inc.. Hikma Americas Inc. served on 10/3/2014, answer due 10/24/2014. (Bourke, Mary) (Entered: 10/06/2014)
2014-10-06
1
SUMMONS Returned Executed by Takeda Pharmaceuticals U.S.A., Inc.. Hikma Pharmaceuticals PLC served on 10/3/2014, answer due 10/24/2014. (Bourke, Mary) (Entered: 10/06/2014)
2014-10-06
1
MOTION for Pro Hac Vice Appearance of Attorney James F. Hurst, Steffen N. Johnson, Charles B. Klein and Samuel S. Park - filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) (Main Document 14 replaced on 10/8/2014) (nmfn, ). (Entered: 10/06/2014)
2014-10-06
1
NOTICE OF SERVICE of Plaintiff Takeda Pharmaceuticals U.S.A., Inc.s Motion for a Temporary Restraining Order and Preliminary Injunction; Plaintiff Takeda Pharmaceuticals U.S.A., Inc.s Brief in Support of its Motion for a Temporary Restraining Order and Preliminary Injunction; Declaration of Chad S. Boomershine, M.D. in Support of Plaintiff Takeda Pharmaceuticals U.S.A., Inc.s Motion for a Temporary Restraining Order and Preliminary Injunction; Declaration of Matthew Woods in Support of Takedas Motion for a Temporary Restraining Order and Preliminary Injunction; and Declaration of Mary W. Bourke in Support of Plaintiff Takeda Pharmaceuticals U.S.A., Inc.s Motion for a Temporary Restraining Order and Preliminary Injunction re 8 Declaration, 6 Opening Brief in Support, 5 MOTION for Temporary Restraining Order and Preliminary Injunction, 7 Declaration, 9 Declaration,, filed by Takeda Pharmaceuticals U.S.A., Inc..(Bourke, Mary) (Entered: 10/06/2014)
2014-10-06
1
Set Hearings: A Telephone Conference is set for 10/8/2014 at 11:30 AM before Judge Sue L. Robinson. Counsel for plaintiff shall coordinate and initiate the call. (nmfn)
2014-10-06
1
No Actions
MOTION for Pro Hac Vice Appearance of Attorney Tryn T. Stimart - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Bourke, Mary) (Entered: 10/08/2014)
2014-10-08
1
MOTION for Pro Hac Vice Appearance of Attorney Eric K. Chiu, Ted Dane, Amy Greywitt and Jeffrey I. Weinberger - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Bourke, Mary) (Entered: 10/08/2014)
2014-10-08
1
[SEALED] RESPONSE to Motion re 5 MOTION for Temporary Restraining Order and Preliminary Injunction -- Defedants' Preliminary Oppostion to Takeda's Motion for a Temporary Restraining Order-- filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) (Entered: 10/08/2014)
2014-10-08
1
[SEALED] DECLARATION re 18 Response to Motion, Declaration of Dominick T. Gattuso by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Exhibits 1-2)(Gattuso, Dominick) (Entered: 10/08/2014)
2014-10-08
1
REPLY BRIEF re 5 MOTION for Temporary Restraining Order and Preliminary Injunction Takeda's Response to Defendants' Preliminary Opposition to Takeda's Motion for Temporary Restraining Order filed by Takeda Pharmaceuticals U.S.A., Inc.. (Bourke, Mary) (Entered: 10/08/2014)
2014-10-08
1
CORRECTING ENTRY: The pdf of D.I. 14 has been replaced with a corrected version per request of filer. (nmfn)
2014-10-08
1
No Actions
Minute Entry for proceedings held before Judge Sue L. Robinson - Telephone Conference held on 10/8/2014. (Court Reporter V. Gunning.) (nmfn)
2014-10-08
1
No Actions
Case Assigned to Judge Sue L. Robinson. Please include the initials of the Judge (SLR) after the case number on all documents filed. (rjb)
2014-10-08
1
No Actions
MEMORANDUM ORDER granting 5 MOTION for Temporary Restraining Order filed by Takeda Pharmaceuticals U.S.A., Inc. ORDER Setting Teleconference: Counsel for Takeda to initiate the call.( A Telephone Conference is set for 10/14/2014 at 01:00 PM before Judge Sue L. Robinson). Signed by Judge Sue L. Robinson on 10/9/2014. (nmfn)
2014-10-09
1
SO ORDERED, re 16 MOTION for Pro Hac Vice Appearance of Attorney Tryn T. Stimart filed by Takeda Pharmaceuticals U.S.A., Inc., 17 MOTION for Pro Hac Vice Appearance of Attorney Eric K. Chiu, Ted Dane, Amy Greywitt and Jeffrey I. Weinberger filed by Takeda Pharmaceuticals U.S.A., Inc., 14 MOTION for Pro Hac Vice Appearance of Attorney James F. Hurst, Steffen N. Johnson, Charles B. Klein and Samuel S. Park filed by West-Ward Pharmaceutical Corporation, Hikma Pharmaceuticals PLC, Hikma Americas Inc. Signed by Judge Sue L. Robinson on 10/10/2014. (fms)
2014-10-10
1
No Actions
MOTION for Pro Hac Vice Appearance of Attorney Elaine Herrmann Blais, William G. James, Elizabeth J. Holland and John T. Bennett - filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) (Entered: 10/13/2014)
2014-10-13
1
[SEALED] Letter to The Honorable Sue L. Robinson from Dominick T. Gattuso regarding Brief Schedule - re 21 Memorandum and Order,, Order Setting Teleconference,. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Gattuso, Dominick) (Entered: 10/14/2014)
2014-10-14
1
Joint STIPULATION and Proposed Order for Brief Scheduling re 23 Letter by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) (Entered: 10/14/2014)
2014-10-14
1
ORDER setting briefing schedule (Answering Brief due 10/17/2014., Supplemental Brief due 10/20/2014., Reply Brief due 10/24/2014.), ORDER, Setting Hearings( An Oral Argument is set for 10/30/2014 at 10:00 AM in Courtroom 4B before Judge Sue L. Robinson.). Signed by Judge Sue L. Robinson on 10/14/2014. (nmfn) (Entered: 10/14/2014)
2014-10-14
1
REDACTED VERSION of 6 Opening Brief in Support, by Takeda Pharmaceuticals U.S.A., Inc.. (Bourke, Mary) (Entered: 10/14/2014)
2014-10-14
1
REDACTED VERSION of 8 Declaration of Matthew Woods in Support of Takeda's Motion for a Temporary Restraining Order and Preliminary Injunction by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit A)(Bourke, Mary) (Entered: 10/14/2014)
2014-10-14
1
REDACTED VERSION of 9 Declaration,, of Mary W. Bourke in Support of Plaintiff Takeda Pharmaceuticals U.S.A., Inc.'s Motion for a Temporary Restraining Order and Preliminary Injunction by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V)(Bourke, Mary) (Entered: 10/14/2014)
2014-10-14
1
Pro Hac Vice Attorney James F. Hurst for West-Ward Pharmaceutical Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (els)
2014-10-14
1
No Actions
Pro Hac Vice Attorney Steffen N. Johnson for West-Ward Pharmaceutical Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (els)
2014-10-14
1
No Actions
Pro Hac Vice Attorney Charles B. Klein for West-Ward Pharmaceutical Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (els)
2014-10-14
1
No Actions
Pro Hac Vice Attorney Samuel S. Park for West-Ward Pharmaceutical Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (els)
2014-10-14
1
No Actions
SO ORDERED, re 22 MOTION for Pro Hac Vice Appearance of Attorney Elaine Herrmann Blais, William G. James, Elizabeth J. Holland and John T. Bennett filed by West-Ward Pharmaceutical Corporation, Hikma Pharmaceuticals PLC, Hikma Americas Inc. Signed by Judge Sue L. Robinson on 10/14/2014. (fms)
2014-10-14
1
No Actions
Minute Entry for proceedings held before Judge Sue L. Robinson - Telephone Conference held on 10/14/2014. (Court Reporter V. Gunning.) (nmfn)
2014-10-14
1
No Actions
Joint STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to the Complaint to November 17, 2014 - filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) (Entered: 10/15/2014)
2014-10-15
1
REDACTED VERSION of 18 Response to Motion, by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) (Entered: 10/15/2014)
2014-10-15
1
REDACTED VERSION of 19 Declaration by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Exhibits 1-2)(Gattuso, Dominick) (Entered: 10/15/2014)
2014-10-15
1
SO ORDERED, re 29 Joint STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to the Complaint to November 17, 2014 filed by West-Ward Pharmaceutical Corporation, Hikma Pharmaceuticals PLC, Hikma Americas Inc., Set/Reset Answer Deadlines: Hikma Americas Inc. answer due 11/17/2014; Hikma Pharmaceuticals PLC answer due 11/17/2014; West-Ward Pharmaceutical Corporation answer due 11/17/2014. Signed by Judge Sue L. Robinson on 10/15/2014. (fms)
2014-10-15
1
No Actions
Joint STIPULATION and [Proposed] Order That Parties Be Permitted to File Documents Under Seal Pending Entry of a Formal Protective Order by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) (Entered: 10/16/2014)
2014-10-16
1
[SEALED] RESPONSE to Order re 21 Memorandum and Order,, Order Setting Teleconference, Brief Responding to the Court's Questions on the Proposed Temporary Restraining Order filed by Takeda Pharmaceuticals U.S.A., Inc.. (Bourke, Mary) (Entered: 10/16/2014)
2014-10-16
1
[SEALED] DECLARATION re 33 Response to Order, Declaration of Mary W. Bourke In Support of Plaintiff Takeda Pharmaceuticals U.S.A., Inc.'s Brief Responding to the Court's Questions on the Proposed Temporary Restraining Order by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H)(Bourke, Mary) (Entered: 10/16/2014)
2014-10-16
1
[SEALED] RESPONSE to Motion re 5 MOTION for Temporary Restraining Order and Preliminary Injunction -- Defendants filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Exhibits A-B)(Gattuso, Dominick) (Entered: 10/16/2014)
2014-10-16
1
Compendium of Unreported Decisions re 35 Response to Motion, by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Tabs 1-15)(Gattuso, Dominick) Modified on 1/16/2018 (nms). (Entered: 10/16/2014)
2014-10-16
1
Pro Hac Vice Attorney Elizabeth J. Holland,Elaine H. Blais,John T. Bennett for West-Ward Pharmaceutical Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (dmp, )
2014-10-16
1
No Actions
[SEALED] ANSWERING BRIEF in Opposition re 5 MOTION for Temporary Restraining Order and Preliminary Injunction filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.Reply Brief due date per Local Rules is 10/27/2014. (Gattuso, Dominick) (Entered: 10/17/2014)
2014-10-17
1
DECLARATION re 37 Answering Brief in Opposition, Eric P. Gall, M.D. by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Ex 1)(Gattuso, Dominick) (Entered: 10/17/2014)
2014-10-17
1
[SEALED] DECLARATION re 37 Answering Brief in Opposition, Spiro Gavaris by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Ex A-F Part 1, # 2 Ex A-F Part 2, # 3 Ex A-F Part 3)(Gattuso, Dominick) (Entered: 10/17/2014)
2014-10-17
1
DECLARATION re 37 Answering Brief in Opposition, Joseph J. Saseen by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Ex A)(Gattuso, Dominick) (Entered: 10/17/2014)
2014-10-17
1
[SEALED] DECLARATION re 37 Answering Brief in Opposition, Phillip D. Hansten by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Ex A-M Part 1, # 2 Ex A-M Part 2, # 3 Ex A-M Part 3, # 4 Ex A-M Part 4, # 5 Ex A-M Part 5)(Gattuso, Dominick) (Entered: 10/17/2014)
2014-10-17
1
DECLARATION re 37 Answering Brief in Opposition, Stuart L. Silverman by Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Ex 1)(Gattuso, Dominick) (Entered: 10/17/2014)
2014-10-17
1
DECLARATION re 37 Answering Brief in Opposition, Simon M. Helfgott by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Ex A-P Part 1, # 2 Ex A-P Part 2, # 3 Ex A-P Part 3, # 4 Ex A-P Part 4, # 5 Ex A-P Part 5, # 6 Ex A-P Part 6, # 7 Ex Q-Y Part 1, # 8 Ex Q-Y Part 2, # 9 Ex Q-Y Part 3, # 10 Ex Q-Y Part 4, # 11 Ex Q-Y Part 5, # 12 Ex Q-Y Part 6, # 13 Ex Q-Y Part 7, # 14 Ex Q-Y Part 8, # 15 Ex Q-Y Part 9)(Gattuso, Dominick) (Attachment 3 replaced on 10/20/2014) (nmfn, ). (Entered: 10/17/2014)
2014-10-17
1
[SEALED] DECLARATION re 37 Answering Brief in Opposition, Doug Statler by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) (Entered: 10/17/2014)
2014-10-17
1
DECLARATION re 37 Answering Brief in Opposition, Arthur Y Tsien by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Exhibits A-I)(Gattuso, Dominick) (Entered: 10/17/2014)
2014-10-17
1
[SEALED] DECLARATION re 37 Answering Brief in Opposition, Susan Todd by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Conf. Ex. 1-5 and Ex. 1-10 Part 1, # 2 Conf. Ex. 1-5 and Ex. 1-10 Part 2, # 3 Conf. Ex. 1-5 and Ex. 1-10 Part 3)(Gattuso, Dominick) (Entered: 10/17/2014)
2014-10-17
1
[SEALED] DECLARATION re 37 Answering Brief in Opposition, Joel Rosenstack by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Ex A-C)(Gattuso, Dominick) (Entered: 10/17/2014)
2014-10-17
1
[SEALED] DECLARATION re 37 Answering Brief in Opposition, Timothy Snail by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Ex A-C)(Gattuso, Dominick) (Entered: 10/17/2014)
2014-10-17
1
[SEALED] DECLARATION re 37 Answering Brief in Opposition, Dominick Gattuso by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Ex A-H Part 1, # 2 Ex A-H Part 2, # 3 Ex A-H Part 3)(Gattuso, Dominick) (Entered: 10/17/2014)
2014-10-17
1
SO ORDERED, re 32 Joint STIPULATION and [Proposed] Order That Parties Be Permitted to File Documents Under Seal Pending Entry of a Formal Protective Order filed by West-Ward Pharmaceutical Corporation, Hikma Pharmaceuticals PLC, Hikma Americas Inc. Signed by Judge Sue L. Robinson on 10/17/2014. (fms)
2014-10-17
1
No Actions
CORRECTING ENTRY: The pdf of D.I. 43 Exhibit A-P Part 3 has been replaced with a corrected version per request of filer. (nmfn)
2014-10-20
1
No Actions
MOTION for Pro Hac Vice Appearance of Attorney Elizabeth A. Laughton - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Bourke, Mary) (Entered: 10/21/2014)
2014-10-21
1
REDACTED VERSION of 23 Letter by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Gattuso, Dominick) (Entered: 10/21/2014)
2014-10-21
1
SO ORDERED, re 50 MOTION for Pro Hac Vice Appearance of Attorney Elizabeth A. Laughton filed by Takeda Pharmaceuticals U.S.A., Inc.. Signed by Judge Sue L. Robinson on 10/21/2014. (fms)
2014-10-21
1
No Actions
Pro Hac Vice Attorney William G. James for West-Ward Pharmaceutical Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (dmp, )
2014-10-21
1
No Actions
REDACTED VERSION of 33 Response to Order, (Brief Responding to the Court's Questions on the Proposed Temporary Restraining Order) by Takeda Pharmaceuticals U.S.A., Inc.. (Bourke, Mary) (Entered: 10/23/2014)
2014-10-23
1
REDACTED VERSION of 34 Declaration, (Declaration of Mary W. Bourke In Support of Plaintiff Takeda Pharmaceuticals U.S.A., Inc.'s Brief Responding to the Court's Questions on the Proposed Temporary Restraining Order) by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H)(Bourke, Mary) (Entered: 10/23/2014)
2014-10-23
1
Joint STIPULATION TO EXTEND TIME for the Temporary Restraining Order to November 4, 2014 - filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) (Entered: 10/23/2014)
2014-10-23
1
Joint PROPOSED ORDER Interim Stipulated Protective Order by Takeda Pharmaceuticals U.S.A., Inc.. (Bourke, Mary) (Entered: 10/23/2014)
2014-10-23
1
REDACTED VERSION of 35 Response to Motion, by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Exhibits A-B)(Gattuso, Dominick) (Entered: 10/23/2014)
2014-10-23
1
REDACTED VERSION of 37 Answering Brief in Opposition, by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) (Entered: 10/24/2014)
2014-10-24
1
REDACTED VERSION of 49 Declaration, of Dominick Gattuso by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Exhibits A-H Part 1, # 2 Exhibits A-H Part 2, # 3 Exhibits A-H Part 3)(Gattuso, Dominick) (Entered: 10/24/2014)
2014-10-24
1
REDACTED VERSION of 39 Declaration, of Spiro Gavaris by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Exhibits A-F)(Gattuso, Dominick) (Entered: 10/24/2014)
2014-10-24
1
REDACTED VERSION of 41 Declaration, of Phillip D. Hansten by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Exhibits A-M)(Gattuso, Dominick) (Entered: 10/24/2014)
2014-10-24
1
REDACTED VERSION of 47 Declaration of Joel Rosenstack by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) (Entered: 10/24/2014)
2014-10-24
1
REDACTED VERSION of 46 Declaration, of Susan Todd by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Conf Ex. 1-5 and Ex. 1-10 Part 1, # 2 Conf Ex. 1-5 and Ex. 1-10 Part 2)(Gattuso, Dominick) (Entered: 10/24/2014)
2014-10-24
1
REDACTED VERSION of 46 Declaration, of Susan Todd by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Conf Ex. 1-5 and Ex. 1-10 Part 1, # 2 Conf Ex. 1-5 and Ex. 1-10 Part 2)(Gattuso, Dominick) (Entered: 10/24/2014)
2014-10-24
2
REDACTED VERSION of 46 Declaration, of Susan Todd by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Conf Ex. 1-5 and Ex. 1-10 Part 1, # 2 Conf Ex. 1-5 and Ex. 1-10 Part 2)(Gattuso, Dominick) (Entered: 10/24/2014)
2014-10-24
2
REDACTED VERSION of 44 Declaration of Doug Statler by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) (Entered: 10/24/2014)
2014-10-24
1
REDACTED VERSION of 48 Declaration of Timothy Snail by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Exhibits A-C)(Gattuso, Dominick) (Entered: 10/24/2014)
2014-10-24
1
[SEALED] REPLY BRIEF re 5 MOTION for Temporary Restraining Order and Preliminary Injunction filed by Takeda Pharmaceuticals U.S.A., Inc.. (Bourke, Mary) (Entered: 10/24/2014)
2014-10-24
1
DECLARATION re 65 Reply Brief of Chad S. Boomershine by Takeda Pharmaceuticals U.S.A., Inc.. (Bourke, Mary) (Entered: 10/24/2014)
2014-10-24
1
[SEALED] DECLARATION re 65 Reply Brief Matthew Woods by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit A)(Bourke, Mary) (Entered: 10/24/2014)
2014-10-24
1
[SEALED] DECLARATION re 65 Reply Brief Mary W. Bourke by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D)(Bourke, Mary) (Entered: 10/24/2014)
2014-10-24
1
[SEALED] DECLARATION re 65 Reply Brief Pierre-Yves Cermieux by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)(Bourke, Mary) (Entered: 10/24/2014)
2014-10-24
1
DECLARATION re 65 Reply Brief Allan H. Morton by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R)(Bourke, Mary) (Entered: 10/24/2014)
2014-10-24
1
MOTION for Pro Hac Vice Appearance of Attorney John K. Hsu - filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) (Entered: 10/27/2014)
2014-10-27
1
SO ORDERED, re 71 MOTION for Pro Hac Vice Appearance of Attorney John K. Hsu filed by West-Ward Pharmaceutical Corporation, Hikma Pharmaceuticals PLC, Hikma Americas Inc. Signed by Judge Sue L. Robinson on 10/28/2014. (fms)
2014-10-28
1
No Actions
SO ORDERED, re 55 Interim Stipulated Protective Order filed by Takeda Pharmaceuticals U.S.A., Inc. Signed by Judge Sue L. Robinson on 10/28/2014. (fms)
2014-10-28
1
No Actions
SO ORDERED, re 54 Joint STIPULATION TO EXTEND TIME for the Temporary Restraining Order to November 4, 2014 filed by West-Ward Pharmaceutical Corporation, Hikma Pharmaceuticals PLC, Hikma Americas Inc. Signed by Judge Sue L. Robinson on 10/28/2014. (fms)
2014-10-28
1
No Actions
Pro Hac Vice Attorney Elizabeth A. Laughton for Takeda Pharmaceuticals U.S.A., Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (els)
2014-10-29
1
No Actions
Pro Hac Vice Attorney Jeffrey I. Weinberger for Takeda Pharmaceuticals U.S.A., Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (els)
2014-10-29
1
No Actions
Pro Hac Vice Attorney Eric K. Chiu for Takeda Pharmaceuticals U.S.A., Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (els)
2014-10-29
1
No Actions
Pro Hac Vice Attorney Ted G. Dane for Takeda Pharmaceuticals U.S.A., Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (els)
2014-10-29
1
No Actions
Pro Hac Vice Attorney John K. Hsu for West-Ward Pharmaceutical Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (els)
2014-10-29
1
No Actions
Minute Entry for proceedings held before Judge Sue L. Robinson - Oral Argument held on 10/30/2014. (Court Reporter V. Gunning.) (nmfn)
2014-10-30
1
No Actions
TEMPORARY RESTRAINING ORDER. Signed by Judge Sue L. Robinson on 10/31/2014. (nmfn) (Entered: 10/31/2014)
2014-10-31
1
REDACTED VERSION of 65 Reply Brief in Support of its Motion for Preliminary Injunction by Takeda Pharmaceuticals U.S.A., Inc.. (Bourke, Mary) (Entered: 10/31/2014)
2014-10-31
1
REDACTED VERSION of 67 Declaration of Matthew Woods by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit A)(Bourke, Mary) (Entered: 10/31/2014)
2014-10-31
1
REDACTED VERSION of 68 Declaration of Mary W. Bourke in Support of Takeda's Reply in Support of its Motion for Preliminary injunction by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit A-D)(Bourke, Mary) (Entered: 10/31/2014)
2014-10-31
1
REDACTED VERSION of 69 Declaration, of Pierre-Yves Cermieux by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)(Bourke, Mary) (Entered: 10/31/2014)
2014-10-31
1
Pro Hac Vice Attorney Amy L. Greywitt for Takeda Pharmaceuticals U.S.A., Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (dmp, )
2014-10-31
1
No Actions
[SEALED] NOTICE of by Takeda Pharmaceuticals U.S.A., Inc. Temporary Restraining Order Bond (Bourke, Mary) (Entered: 11/03/2014)
2014-11-03
1
MEMORANDUM OPINION. Signed by Judge Sue L. Robinson on 11/4/2014. (nmfn)
2014-11-04
1
ORDER denying Takeda's 5 MOTION for Preliminary Injunction. IT IS FURTHER ORDERED that the status quo will be maintained pending appeal if: (1) Takeda takes an immediate appeal and requests expedited review of both the merits and this ruling by the Federal Circuit; and (2) the conditions included in the court's order issued on October 31, 2014 (D.I. 72 ) continue to govern the conduct of the parties, except that the bond shall increase $500,000 per day until further order of this court or the Federal Circuit. Signed by Judge Sue L. Robinson on 11/4/2014. (nmfn) (Entered: 11/04/2014)
2014-11-04
1
NOTICE OF APPEAL to the Federal Circuit of 79 Order,, . Appeal filed by Takeda Pharmaceuticals U.S.A., Inc.. (Bourke, Mary) (Entered: 11/05/2014)
2014-11-05
1
APPEAL - Credit Card Payment of $505.00 received re 80 Notice of Appeal (Federal Circuit) filed by Takeda Pharmaceuticals U.S.A., Inc.. ( Filing fee $505, receipt number 0311-1621009.) (Bourke, Mary)
2014-11-05
1
No Actions
Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re 80 Notice of Appeal (Federal Circuit). (dmp, )
2014-11-05
1
No Actions
NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re 80 Notice of Appeal (Federal Circuit) filed by Takeda Pharmaceuticals U.S.A., Inc. USCA Case Number 15-1139. (fms) (Entered: 11/07/2014)
2014-11-07
1
NOTICE OF CROSS APPEAL to the Federal Circuit of 78 Memorandum Opinion, 79 Order,, . Cross Appeal filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) (Entered: 11/10/2014)
2014-11-10
1
Notice of Cross Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re 82 Notice of Cross Appeal. (dmp, )
2014-11-10
1
No Actions
APPEAL - Credit Card Payment of $505.00 received re 82 Notice of Cross Appeal filed by West-Ward Pharmaceutical Corporation, Hikma Pharmaceuticals PLC, Hikma Americas Inc.. ( Filing fee $505, receipt number 0311-1623164.) (Gattuso, Dominick)
2014-11-10
1
No Actions
Joint STIPULATION TO EXTEND TIME to Respond to the Complaint to December 5, 2014 - filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) (Entered: 11/13/2014)
2014-11-13
1
SO ORDERED, re 83 Joint STIPULATION TO EXTEND TIME to Respond to the Complaint to December 5, 2014 filed by West-Ward Pharmaceutical Corporation, Hikma Pharmaceuticals PLC, Hikma Americas Inc., Set/Reset Answer Deadlines: Hikma Americas Inc. answer due 12/5/2014; Hikma Pharmaceuticals PLC answer due 12/5/2014; West-Ward Pharmaceutical Corporation answer due 12/5/2014. Signed by Judge Sue L. Robinson on 11/14/2014. (fms)
2014-11-14
1
No Actions
NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re 82 Notice of Cross Appeal filed by West-Ward Pharmaceutical Corporation, Hikma Pharmaceuticals PLC, Hikma Americas Inc. USCA Case Number 15-1142 (fms) (Entered: 11/17/2014)
2014-11-17
1
[SEALED] NOTICE of by Takeda Pharmaceuticals U.S.A., Inc. Rider to Bond (Bourke, Mary) (Entered: 11/20/2014)
2014-11-20
1
[SEALED] NOTICE of Rider to Bond by Takeda Pharmaceuticals U.S.A., Inc. (Bourke, Mary) (Entered: 12/03/2014)
2014-12-03
1
REDACTED VERSION of 85 Notice (Other) Rider to Bond by Takeda Pharmaceuticals U.S.A., Inc.. (Bourke, Mary) (Entered: 12/03/2014)
2014-12-03
1
REDACTED VERSION of 86 Notice (Other) Rider to Bond by Takeda Pharmaceuticals U.S.A., Inc.. (Bourke, Mary) (Entered: 12/05/2014)
2014-12-05
1
MOTION to Dismiss for Failure to State a Claim - filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Text of Proposed Order)(Gattuso, Dominick) (Entered: 12/05/2014)
2014-12-05
1
OPENING BRIEF in Support re 89 MOTION to Dismiss for Failure to State a Claim filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.Answering Brief/Response due date per Local Rules is 12/22/2014. (Gattuso, Dominick) (Entered: 12/05/2014)
2014-12-05
1
REDACTED VERSION of 77 Notice (Other) Temporary Restraining Order Bond by Takeda Pharmaceuticals U.S.A., Inc.. (Bourke, Mary) (Entered: 12/08/2014)
2014-12-08
1
REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI # 77. (fms)
2014-12-08
1
No Actions
NOTICE of of Lodging by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation (Attachments: # 1 Exhibits A-C Part 1, # 2 Exhibits A-C Part 2)(Gattuso, Dominick) (Entered: 12/09/2014)
2014-12-09
1
STIPULATION TO EXTEND TIME to respond to Defendants' Motion to Dismiss to January 30, 2015 - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Bourke, Mary) (Entered: 12/10/2014)
2014-12-10
1
SO ORDERED, re 93 STIPULATION TO EXTEND TIME to respond to Defendants' Motion to Dismiss to January 30, 2015 filed by Takeda Pharmaceuticals U.S.A., Inc., Set Briefing Schedule: re 89 MOTION to Dismiss for Failure to State a Claim . (Answering Brief due 1/30/2015.) Signed by Judge Sue L. Robinson on 12/11/2014. (fms)
2014-12-11
1
No Actions
NOTICE of Withdrawal by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation (Gattuso, Dominick) (Entered: 12/19/2014)
2014-12-19
1
[SEALED] NOTICE of Rider to Bond by Takeda Pharmaceuticals U.S.A., Inc. (Bourke, Mary) (Entered: 01/09/2015)
2015-01-09
1
REDACTED VERSION of 95 Notice (Other) Rider to Bond by Takeda Pharmaceuticals U.S.A., Inc.. (Bourke, Mary) (Entered: 01/09/2015)
2015-01-09
1
ORDER of USCA as to 82 Notice of Cross Appeal filed by West-Ward Pharmaceutical Corporation, Hikma Pharmaceuticals PLC, Hikma Americas Inc., 80 Notice of Appeal (Federal Circuit) filed by Takeda Pharmaceuticals U.S.A., Inc. Decision of USCA: The district court's order denying Takeda Pharmaceuticals U.S.A., Inc.'s motion for preliminary injunction is affirmed, opinion to follow. (fms) (Entered: 01/12/2015)
2015-01-09
1
Letter to the Honorable Sue. L. Robinson from Dominick T. Gattuso regarding recent rulings. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Gattuso, Dominick) (Entered: 01/12/2015)
2015-01-12
1
Letter to the Honorable Sue L. Robinson from Dominick T. Gattuso regarding Defendants Renewed Email Request for Emergency Relief. (Gattuso, Dominick) (Entered: 01/12/2015)
2015-01-12
1
Joint STIPULATION TO EXTEND TIME to Respond to Defendants' Motion to Dismiss to two weeks from the date upon which the United States Court of Appeals for the Federal Circuit issues its Opinion regarding this matter - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Bourke, Mary) (Entered: 01/27/2015)
2015-01-27
1
SO ORDERED, re 100 Joint STIPULATION TO EXTEND TIME to Respond to Defendants' Motion to Dismiss to two weeks from the date upon which the United States Court of Appeals for the Federal Circuit issues its Opinion regarding this matter. Signed by Judge Sue L. Robinson on 1/27/2015. (nmfn)
2015-01-27
1
No Actions
[SEALED] Joint STIPULATION to lift January 9, 2015 bond rider re 95 Notice (Other) by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Certificate of Service)(Attaway, Daniel) (Entered: 02/20/2015)
2015-02-20
1
SO ORDERED, re 101 SEALED Stipulation filed by Takeda Pharmaceuticals U.S.A., Inc. Signed by Judge Sue L. Robinson on 2/24/2015. (fms)
2015-02-24
1
No Actions
REDACTED VERSION of 101 Stipulation and Order by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Certificate of Service)(Bourke, Mary) (Entered: 03/02/2015)
2015-03-02
1
[SEALED] ORDER re 101 Stipulation filed by Takeda Pharmaceuticals U.S.A., Inc. Signed by Judge Sue L. Robinson on 3/12/2015.This order has been emailed to local counsel. (nmfn) (Entered: 03/12/2015)
2015-03-12
1
NOTICE requesting Clerk to remove John K. Hsu as co-counsel. Reason for request: no longer with the Winston & Strawn LLP. (Gattuso, Dominick) (Entered: 04/07/2015)
2015-04-07
1
MOTION for Pro Hac Vice Appearance of Attorney Heather E. Takahashi - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attaway, Daniel) (Entered: 06/02/2015)
2015-06-02
1
SO ORDERED, re 105 MOTION for Pro Hac Vice Appearance of Attorney Heather E. Takahashi filed by Takeda Pharmaceuticals U.S.A., Inc. Signed by Judge Sue L. Robinson on 6/3/2015. (fms)
2015-06-03
1
No Actions
SO ORDERED
2015-06-03
1
No Actions
Pro Hac Vice Attorney Heather E. Takahashi for Takeda Pharmaceuticals U.S.A., Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (dmp, )
2015-06-05
1
No Actions
Add Attorneys - PHV only
2015-06-05
1
No Actions
Joint STIPULATION TO EXTEND TIME to respond to Defendants' Motion to Dismiss shall be two weeks from the date upon which the Court of Appeals issues its mandate and the date by which Defendants shall reply to Plaintiffs' response to Defendants' Motion shall now be two weeks from the date upon which Plaintiff files its responsive brief - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attaway, Daniel) (Entered: 08/12/2015)
2015-08-12
1
SO ORDERED, re 106 Joint STIPULATION TO EXTEND TIME to respond to Defendants' Motion to Dismiss shall be two weeks from the date upon which the Court of Appeals issues its mandate and the date by which Defendants shall reply to Plaintiffs' response to Defendan filed by Takeda Pharmaceuticals U.S.A., Inc. Signed by Judge Sue L. Robinson on 8/14/2015. (fms)
2015-08-14
1
No Actions
SO ORDERED
2015-08-14
1
No Actions
MANDATE of USCA as to 82 Notice of Cross Appeal filed by West-Ward Pharmaceutical Corporation, Hikma Pharmaceuticals PLC, Hikma Americas Inc., 80 Notice of Appeal (Federal Circuit) filed by Takeda Pharmaceuticals U.S.A., Inc.. USCA Decision: The main appeal is affirmed. The cross-appeal is dismissed as moot. (Attachments: # 1 order, # 2 mandate)(fms) (Entered: 08/26/2015)
2015-08-26
1
Consent MOTION for Leave to File a First Amended Complaint - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Amended Complaint and Exhibits A-F - Part 1, # 2 Exhibit G-J to Amended Complaint - Part 2, # 3 Exhibit K-M to Amended Complaint - Part 3, # 4 Exhibit B to Motion for Leave, # 5 Text of Proposed Order Exhibit C to Motion for Leave)(Bourke, Mary) (Entered: 09/09/2015)
2015-09-09
1
FIRST AMENDED COMPLAINT against Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation- filed by Takeda Pharmaceuticals U.S.A., Inc. (Attachments: # 1 Exhibits G-J, # 2 Exhibits K-M)(fms) (Entered: 09/10/2015)
2015-09-10
1
FIRST AMENDED COMPLAINT against Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation- filed by Takeda Pharmaceuticals U.S.A., Inc. (Attachments: # 1 Exhibits G-J, # 2 Exhibits K-M)(fms) (Entered: 09/10/2015)
2015-09-10
2
FIRST AMENDED COMPLAINT against Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation- filed by Takeda Pharmaceuticals U.S.A., Inc. (Attachments: # 1 Exhibits G-J, # 2 Exhibits K-M)(fms) (Entered: 09/10/2015)
2015-09-10
2
PATENT REPORT NOTICE: Please note that if patents are being added to this case, the filing party should complete the Report to Commissioner of Patents & Trademarks, and enter it on the docket using the PATENT/TRADEMARK REPORT event in the OTHER DOCUMENT list. The patent report form can be found at www.ded.uscourts.gov under the Clerk's Office FORMS button. (fms)
2015-09-10
1
No Actions
SO ORDERED, re 108 Consent MOTION for Leave to File a First Amended Complaint filed by Takeda Pharmaceuticals U.S.A., Inc.. Signed by Judge Sue L. Robinson on 9/10/2015. (fms)
2015-09-10
1
No Actions
Patent Report Notice to Counsel
2015-09-10
1
No Actions
SO ORDERED
2015-09-10
1
No Actions
STIPULATION and Order to extend the date by which Defendants shall answer, move or otherwise respond to the First Amended Complaint to October 1, 2015 re 109 Amended Complaint by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) (Entered: 09/15/2015)
2015-09-15
1
SO ORDERED, re 110 Stipulation, filed by West-Ward Pharmaceutical Corporation, Hikma Pharmaceuticals PLC, Hikma Americas Inc., Set/Reset Answer Deadlines: Hikma Americas Inc. answer due 10/1/2015; Hikma Pharmaceuticals PLC answer due 10/1/2015; West-Ward Pharmaceutical Corporation answer due 10/1/2015. Signed by Judge Sue L. Robinson on 9/16/2015. (fms)
2015-09-16
1
No Actions
~Util - Set/Reset Answer Deadline AND SO ORDERED
2015-09-16
1
No Actions
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,619,004, 7,964,647; 7,964,648; 7,981,938; 8,093,297, 8,097,655; 8,415,395, 8,440,722; . (Attaway, Daniel) (Entered: 09/22/2015)
2015-09-22
1
MOTION to Dismiss for Failure to State a Claim -- Defendants' Motion to Dismiss Plaintiff's First Amended Complaint -- - filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Text of Proposed Order)(Gattuso, Dominick) (Entered: 10/01/2015)
2015-10-01
1
OPENING BRIEF in Support re 112 MOTION to Dismiss for Failure to State a Claim -- Defendants' Motion to Dismiss Plaintiff's First Amended Complaint -- filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.Answering Brief/Response due date per Local Rules is 10/19/2015. (Gattuso, Dominick) (Entered: 10/01/2015)
2015-10-01
1
STIPULATION TO EXTEND TIME for Plaintiff to respond to Defendants' Motion to Dismiss and for Defendants to reply to Plaintiff's response to Motion to Dismiss to Plaintiff's Response: October 26, 2015 and Defendants' Reply: November 16, 2015 - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attaway, Daniel) (Entered: 10/08/2015)
2015-10-08
1
SO ORDERED, re 114 STIPULATION TO EXTEND TIME filed by Takeda Pharmaceuticals U.S.A., Inc., Set Briefing Schedule: re 112 MOTION to Dismiss for Failure to State a Claim -- Defendants' Motion to Dismiss Plaintiff's First Amended Complaint --. (Answering Brief due 10/26/2015., Reply Brief due 11/16/2015.). Signed by Judge Sue L. Robinson on 10/8/2015. (fms)
2015-10-08
1
No Actions
~Util - Set Briefing Schedule - open,ans,reply,surreply AND SO ORDERED
2015-10-08
1
No Actions
ANSWERING BRIEF in Opposition re 112 MOTION to Dismiss for Failure to State a Claim -- Defendants' Motion to Dismiss Plaintiff's First Amended Complaint -- filed by Takeda Pharmaceuticals U.S.A., Inc..Reply Brief due date per Local Rules is 11/5/2015. (Bourke, Mary) (Entered: 10/26/2015)
2015-10-26
1
MOTION for Pro Hac Vice Appearance of Attorney Hannah Dubina - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attaway, Daniel) (Entered: 10/26/2015)
2015-10-26
1
SO ORDERED
2015-10-27
1
No Actions
SO ORDERED, re 116 MOTION for Pro Hac Vice Appearance of Attorney Hannah Dubina filed by Takeda Pharmaceuticals U.S.A., Inc. Signed by Judge Sue L. Robinson on 10/27/2015. (fms)
2015-10-27
1
No Actions
Add Attorneys - PHV only
2015-10-29
1
No Actions
Pro Hac Vice Attorney Hannah Dubina for Takeda Pharmaceuticals U.S.A., Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (dmp, )
2015-10-29
1
No Actions
REPLY BRIEF re 112 MOTION to Dismiss for Failure to State a Claim -- Defendants' Motion to Dismiss Plaintiff's First Amended Complaint -- filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) (Entered: 11/16/2015)
2015-11-16
1
REQUEST for Oral Argument by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation re 112 MOTION to Dismiss for Failure to State a Claim -- Defendants' Motion to Dismiss Plaintiff's First Amended Complaint --. (Gattuso, Dominick) (Entered: 11/16/2015)
2015-11-16
1
EXHIBIT re 117 Reply Brief, by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Letter to Judge Robinson)(Gattuso, Dominick) (Entered: 11/23/2015)
2015-11-23
1
ORDER, Setting Hearings( An Oral Argument is set for 3/29/2016 at 10:00 AM in Courtroom 4B before Judge Sue L. Robinson.). Signed by Judge Sue L. Robinson on 3/4/2016. (nmfn) (Entered: 03/04/2016)
2016-03-04
1
Oral Argument
2016-03-29
1
No Actions
Minute Entry for proceedings held before Judge Sue L. Robinson - Oral Argument held on 3/29/2016. (Court Reporter V. Gunning.) (nmfn)
2016-03-29
1
No Actions
MEMORANDUM OPINION. Signed by Judge Sue L. Robinson on 5/18/2016. (nmfn)
2016-05-18
1
ORDER granting 112 Motion to Dismiss (CASE CLOSED). Signed by Judge Sue L. Robinson on 5/18/2016. (nmfn) (Entered: 05/18/2016)
2016-05-18
1
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,619,004, 7,964,647; 7,964,648; 7,981,938; 8,093,297, 8,097,655; 8,415,395, 8,440,722. (Attachments: # 1 Memorandum Opinion, # 2 Order)(nmfn) (Entered: 05/18/2016)
2016-05-18
1
MOTION to Alter Judgment of Dismissal and for Leave to Amend its Complaint - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit A-F to Complaint, # 3 Exhibit G-M to Complaint, # 4 Exhibit N-P to Complaint, # 5 Exhibit B, # 6 Text of Proposed Order)(Bourke, Mary) (Entered: 06/03/2016)
2016-06-03
1
OPENING BRIEF in Support re 124 MOTION to Alter Judgment of Dismissal and for Leave to Amend its Complaint filed by Takeda Pharmaceuticals U.S.A., Inc..Answering Brief/Response due date per Local Rules is 6/20/2016. (Attachments: # 1 1)(Bourke, Mary) (Entered: 06/03/2016)
2016-06-03
1
STIPULATION TO EXTEND TIME and Order to file their Brief in Response to the Motion to Alter Judgment and for Leave to Amend its Complaint to June 27, 2016 - filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) (Entered: 06/14/2016)
2016-06-14
1
~Util - Set Briefing Schedule - open,ans,reply,surreply AND SO ORDERED
2016-06-14
1
No Actions
SO ORDERED, re 126 STIPULATION TO EXTEND TIME and Order to file their Brief in Response to the Motion to Alter Judgment and for Leave to Amend its Complaint to June 27, 2016 filed by West-Ward Pharmaceutical Corporation, Hikma Pharmaceuticals PLC, Hikma Americas Inc., Set Briefing Schedule: re 124 MOTION to Alter Judgment of Dismissal and for Leave to Amend its Complaint. (Answering Brief due 6/27/2016.). Signed by Judge Sue L. Robinson on 6/14/2016. (fms)
2016-06-14
1
No Actions
ANSWERING BRIEF in Opposition re 124 MOTION to Alter Judgment of Dismissal and for Leave to Amend its Complaint (Defendants' Opposition to Plaintiff's Motion to Reopen and Amend Complaint) filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.Reply Brief due date per Local Rules is 7/8/2016. (Gattuso, Dominick) (Entered: 06/27/2016)
2016-06-27
1
NOTICE of Change of Address by Dominick T. Gattuso (Gattuso, Dominick) (Entered: 06/30/2016)
2016-06-30
1
REPLY BRIEF re 124 MOTION to Alter Judgment of Dismissal and for Leave to Amend its Complaint filed by Takeda Pharmaceuticals U.S.A., Inc.. (Bourke, Mary) (Entered: 07/08/2016)
2016-07-08
1
REQUEST for Oral Argument by Takeda Pharmaceuticals U.S.A., Inc. re 124 MOTION to Alter Judgment of Dismissal and for Leave to Amend its Complaint. (Bourke, Mary) (Entered: 07/08/2016)
2016-07-08
1
Letter to The Honorable Sue L. Robinson from Dominick T. Gattuso regarding update on the status of Plaintiff's companion litigation in the U.S. Court of Appeals for the District of Columbia Circuit. (Gattuso, Dominick) (Entered: 11/08/2016)
2016-11-08
1
MEMORANDUM ORDER granting 124 MOTION to Alter Judgment of Dismissal and for Leave to Amend its Complaint. Signed by Judge Sue L. Robinson on 12/14/2016. (nmfn)
2016-12-14
1
Second AMENDED COMPLAINT against All Defendants - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Certificate of Service)(Bourke, Mary) Modified on 12/16/2016 (fms). (Entered: 12/16/2016)
2016-12-15
1
- CORRECTING ENTRY
2016-12-16
1
No Actions
Remark
2016-12-16
1
No Actions
File date for D.I. 133 reset to 12/15/2016. (fms)
2016-12-16
1
No Actions
CORRECTING ENTRY: The amended complaint filed on 12/15/2016 (D.I. 133) has been removed from the docket and will be refiled using the correct docket event, Complaint - Amended. (fms)
2016-12-16
1
No Actions
STIPULATION TO EXTEND TIME to Answer Second Amended Complaint to January 12, 2017 - filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) (Entered: 12/19/2016)
2016-12-19
1
~Util - Set/Reset Answer Deadline AND SO ORDERED
2016-12-19
1
No Actions
SO ORDERED, re 134 STIPULATION TO EXTEND TIME to Answer Second Amended Complaint to January 12, 2017 filed by West-Ward Pharmaceutical Corporation, Hikma Pharmaceuticals PLC, Hikma Americas Inc., Set/Reset Answer Deadlines: Hikma Americas Inc. answer due 1/12/2017; Hikma Pharmaceuticals PLC answer due 1/12/2017; West-Ward Pharmaceutical Corporation answer due 1/12/2017. Signed by Judge Sue L. Robinson on 12/19/2016. (fms)
2016-12-19
1
No Actions
[SEALED] ANSWER to Amended Complaint, re: 133 Amended Complaint,, COUNTERCLAIM against Takeda Pharmaceuticals U.S.A., Inc. by Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation, Hikma Americas Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Certificate of Service)(Gattuso, Dominick) (Entered: 01/12/2017)
2017-01-12
1
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Hikma Pharmaceutical PLC for Hikma Americas Inc., West-Ward Pharmaceutical Corporation filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) (Entered: 01/12/2017)
2017-01-12
1
REDACTED VERSION of 135 Answer to Amended Complaint,, Counterclaim, by West-Ward Pharmaceutical Corporation. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Gattuso, Dominick) (Entered: 01/17/2017)
2017-01-17
1
Order Setting In-Person Patent Scheduling Conference: A Scheduling Conference is set for 2/15/2017 at 04:00 PM in Courtroom 4B before Judge Sue L. Robinson. Signed by Judge Sue L. Robinson on 1/17/2017. (nmfn) (Entered: 01/17/2017)
2017-01-17
1
[SEALED] ANSWER to 135 Answer to Amended Complaint,, Counterclaim, by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Certificate of Service)(Bourke, Mary) (Entered: 02/02/2017)
2017-02-02
1
REDACTED VERSION of 139 Answer to Counterclaim by Takeda Pharmaceuticals U.S.A., Inc.. (Bourke, Mary) (Entered: 02/07/2017)
2017-02-07
1
[SEALED] STIPULATION and Order by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Certificate of Service)(Gattuso, Dominick) (Entered: 02/08/2017)
2017-02-08
1
MOTION for Pro Hac Vice Appearance of Attorney Lauren C. Tortorella - filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) (Entered: 02/08/2017)
2017-02-08
1
MOTION for Pro Hac Vice Appearance of Attorney Ilan Wurman - filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) (Entered: 02/08/2017)
2017-02-08
1
SO ORDERED
2017-02-08
1
No Actions
SO ORDERED, re 141 [SEALED] STIPULATION and Order. Signed by Judge Sue L. Robinson on 2/8/2017. (nmfn)
2017-02-08
1
No Actions
REDACTED VERSION of 141 Stipulation by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) (Entered: 02/09/2017)
2017-02-09
1
SO ORDERED
2017-02-09
1
No Actions
SO ORDERED, re 142 MOTION for Pro Hac Vice Appearance of Attorney Lauren C. Tortorella filed by West-Ward Pharmaceutical Corporation, Hikma Pharmaceuticals PLC, Hikma Americas Inc., 143 MOTION for Pro Hac Vice Appearance of Attorney Ilan Wurman filed by West-Ward Pharmaceutical Corporation, Hikma Pharmaceuticals PLC, Hikma Americas Inc. Signed by Judge Sue L. Robinson on 2/9/2017. (fms)
2017-02-09
1
No Actions
Add Attorneys - PHV only
2017-02-10
1
No Actions
Pro Hac Vice Attorney Ilan Wurman and Lauren C. Tortorella for West-Ward Pharmaceutical Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg)
2017-02-10
1
No Actions
Letter to The Honorable Sue L. Robinson from Mary W. Bourke regarding case schedule. (Attachments: # 1 Exhibit A)(Bourke, Mary) (Entered: 02/14/2017)
2017-02-14
1
PROPOSED ORDER Proposed Patent Case Scheduling Order by Takeda Pharmaceuticals U.S.A., Inc.. (Bourke, Mary) (Entered: 02/14/2017)
2017-02-14
1
MOTION for Pro Hac Vice Appearance of Attorney Robert D. Carroll - filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) (Entered: 02/14/2017)
2017-02-14
1
SO ORDERED
2017-02-15
1
No Actions
Scheduling Conference
2017-02-15
1
No Actions
Minute Entry for proceedings held before Judge Sue L. Robinson - Scheduling Conference held on 2/15/2017. (Court Reporter V. Gunning.) Counsel to submit the final proposed scheduling order to the court. (nmfn)
2017-02-15
1
No Actions
SO ORDERED, re 147 MOTION for Pro Hac Vice Appearance of Attorney Robert D. Carroll filed by West-Ward Pharmaceutical Corporation, Hikma Pharmaceuticals PLC, Hikma Americas Inc. Signed by Judge Sue L. Robinson on 2/15/2017. (fms)
2017-02-15
1
No Actions
Letter to The Honorable Sue L. Robinson from Daniel M. Attaway regarding proposed case scheduling order. (Attaway, Daniel) (Entered: 02/24/2017)
2017-02-24
1
PROPOSED ORDER Proposed Patent Case Scheduling Order by Takeda Pharmaceuticals U.S.A., Inc.. (Attaway, Daniel) (Entered: 02/24/2017)
2017-02-24
1
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Case referred to the Magistrate Judge for discovery. Fact Discovery completed by 10/31/2017. A Status Conference is set for 5/23/2017 at 02:00 PM in Courtroom 4B before Judge Sue L. Robinson Dispositive Motions and Opening Briefs due by 1/2/2018. Answering Briefs due 1/16/2018. Replys Brief due 1/23/2018. An Oral Argument is set for 1/31/2018 at 03:00 PM in Courtroom 4B before Judge Sue L. Robinson. Signed by Judge Sue L. Robinson on 2/28/2017. (nmfn) (Entered: 02/28/2017)
2017-02-28
1
PROPOSED ORDER Stipulated Discovery Confidentiality Order by Takeda Pharmaceuticals U.S.A., Inc.. (Bourke, Mary) (Entered: 02/28/2017)
2017-02-28
1
Add Attorneys - PHV only
2017-02-28
1
No Actions
Pro Hac Vice Attorney Robert D. Carroll for West-Ward Pharmaceutical Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm)
2017-02-28
1
No Actions
NOTICE of Service of Defendants' First Set of Joint Interrogatories to Plaintiff (Nos. 1-2) and Defendants' First Set of Requests for Production of Documents and Things (Nos. 1-10) by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation (Gattuso, Dominick) (Entered: 03/01/2017)
2017-03-01
1
SO ORDERED
2017-03-01
1
No Actions
SO ORDERED, re 151 Proposed Order filed by Takeda Pharmaceuticals U.S.A., Inc.. Signed by Judge Sherry R. Fallon on 3/1/2017. (Polito, Rebecca)
2017-03-01
1
No Actions
ORDER Setting Teleconference: Plaintiff's counsel to initiate the call. A Telephone Conference is set for 4/5/2017 at 3:00 PM Eastern Time before Judge Sherry R. Fallon to discuss ADR. Signed by Judge Sherry R. Fallon on 3/2/17. (cak) (Entered: 03/02/2017)
2017-03-02
1
NOTICE OF SERVICE of (1) Plaintiff's First Set of Requests for Production to West-Ward Pharmaceutical Corporation, Hikma Americas Inc., and Hikma Pharmaceuticals PLC (Nos. 1-26) and (2) Plaintiff's First Set of Interrogatories to West-Ward Pharmaceutical Corporation, Hikma Americas Inc., and Hikma Pharmaceuticals PLC (Nos. 1-20) filed by Takeda Pharmaceuticals U.S.A., Inc..(Bourke, Mary) (Entered: 03/02/2017)
2017-03-02
1
NOTICE of Third Party Subpoena of inVentiv Health, Inc. for the Production of Documents by Takeda Pharmaceuticals U.S.A., Inc. (Attachments: # 1 Exhibit A)(Bourke, Mary) (Entered: 03/02/2017)
2017-03-02
1
NOTICE OF SERVICE of 1) Defendants' Rule 26(a)(1) Initial Disclosures; and 2) Defendants' Second Set of Requests for Production of Documents and Things (Nos. 11-32) filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.(Gattuso, Dominick) (Entered: 03/03/2017)
2017-03-03
1
NOTICE of Change of Address of Munger Tolles & Olson LLP by Takeda Pharmaceuticals U.S.A., Inc. (Bourke, Mary) (Entered: 03/03/2017)
2017-03-03
1
NOTICE OF SERVICE of Plaintiff's Initial Disclosures filed by Takeda Pharmaceuticals U.S.A., Inc..(Bourke, Mary) (Entered: 03/03/2017)
2017-03-03
1
NOTICE OF SERVICE of Plaintiff's First Amended Initial Disclosures filed by Takeda Pharmaceuticals U.S.A., Inc..(Bourke, Mary) (Entered: 03/07/2017)
2017-03-07
1
NOTICE to Take Deposition of Laura Heinz on April 10, 2017 filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.(Gattuso, Dominick) (Entered: 03/17/2017)
2017-03-17
1
NOTICE to Take Deposition of Allison Hoffman on April 17, 2017 filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.(Gattuso, Dominick) (Entered: 03/17/2017)
2017-03-17
1
NOTICE to Take Deposition of Kristen Mangrum on April 13, 2017 filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.(Gattuso, Dominick) (Entered: 03/17/2017)
2017-03-17
1
NOTICE to Take Deposition of Marcus Meadows on April 11, 2017 filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.(Gattuso, Dominick) (Entered: 03/17/2017)
2017-03-17
1
NOTICE to Take Deposition of Jillian Ross on April 18, 2017 filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.(Gattuso, Dominick) (Entered: 03/17/2017)
2017-03-17
1
NOTICE to Take Deposition of Norman Tseng on April 14, 2017 filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.(Gattuso, Dominick) (Entered: 03/17/2017)
2017-03-17
1
NOTICE to Take Deposition of Peter Vanciu on April 12, 2017 filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.(Gattuso, Dominick) (Entered: 03/17/2017)
2017-03-17
1
SUBPOENA filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation directed to Jimmy Ballard (Attachments: # 1 Exhibit 1)(Gattuso, Dominick) (Entered: 03/17/2017)
2017-03-17
1
SUBPOENA filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation directed to Dr. Rodolfo M. Garcia (Attachments: # 1 Exhibit 1)(Gattuso, Dominick) (Entered: 03/17/2017)
2017-03-17
1
SUBPOENA filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation directed to Dr. Yulanda Harrison (Attachments: # 1 Exhibit 1)(Gattuso, Dominick) (Entered: 03/17/2017)
2017-03-17
1
SUBPOENA filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation directed to Dr. Jeffrey C. Noroyan D.P.M (Attachments: # 1 Exhibit 1)(Gattuso, Dominick) (Entered: 03/17/2017)
2017-03-17
1
SUBPOENA filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation directed to Dr. Ariel C. Ponce (Attachments: # 1 Exhibit 1)(Gattuso, Dominick) (Entered: 03/17/2017)
2017-03-17
1
SUBPOENA filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation directed to Dr. Seif M. Saeed (Attachments: # 1 Exhibit 1)(Gattuso, Dominick) (Entered: 03/17/2017)
2017-03-17
1
SUBPOENA filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation directed to Dr. Alice L. Yan (Attachments: # 1 Exhibit 1)(Gattuso, Dominick) (Entered: 03/17/2017)
2017-03-17
1
NOTICE OF SERVICE of Defendants' Delaware Discovery Standard Paragraph 3 Disclosures filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.(Gattuso, Dominick) (Entered: 03/17/2017)
2017-03-17
1
SUBPOENA filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation directed to Jimmy Ballard for April 24, 2017 (Attachments: # 1 Exhibit 1)(Gattuso, Dominick) (Entered: 03/20/2017)
2017-03-20
1
SUBPOENA filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation directed to Dr. Rodolfo M. Garcia for April 27, 2017 (Attachments: # 1 Exhibit 1)(Gattuso, Dominick) (Entered: 03/20/2017)
2017-03-20
1
SUBPOENA filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation directed to Dr. Yulanda Harrison for April 25, 2017 (Attachments: # 1 Exhibit 1)(Gattuso, Dominick) (Entered: 03/20/2017)
2017-03-20
1
SUBPOENA filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation directed to Dr. Ariel C. Ponce for April 19, 2017 (Attachments: # 1 Exhibit 1)(Gattuso, Dominick) (Entered: 03/20/2017)
2017-03-20
1
SUBPOENA filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation directed to Dr. Jeffrey C. Noroyan D.P.M for April 20, 2017 (Attachments: # 1 Exhibit 1)(Gattuso, Dominick) (Entered: 03/20/2017)
2017-03-20
1
SUBPOENA filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation directed to Dr. Seif M. Saeed for April 21, 2017 (Attachments: # 1 Exhibit 1)(Gattuso, Dominick) (Entered: 03/20/2017)
2017-03-20
1
SUBPOENA filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation directed to Dr. Alice L. Yan for April 26, 2017 (Attachments: # 1 Exhibit 1)(Gattuso, Dominick) (Entered: 03/20/2017)
2017-03-20
1
MOTION for Pro Hac Vice Appearance of Attorney Celia R. Choy - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attaway, Daniel) (Entered: 03/22/2017)
2017-03-22
1
SO ORDERED, re 182 MOTION for Pro Hac Vice Appearance of Attorney Celia R. Choy filed by Takeda Pharmaceuticals U.S.A., Inc. Signed by Judge Sue L. Robinson on 3/22/2017. (fms)
2017-03-22
1
No Actions
SO ORDERED
2017-03-22
1
No Actions
Pro Hac Vice Attorney Celia R. Choy for Takeda Pharmaceuticals U.S.A., Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:14-cv-01268-SLR-SRF, 1:16-cv-00987-SLR(ceg)
2017-03-27
1
No Actions
Add Attorneys - PHV only
2017-03-27
1
No Actions
NOTICE OF SERVICE of (1) Plaintiff's Responses to Defendants' First Set of Joint Interrogatories (Nos. 1-2) and (2) Plaintiff's Response to Defendants' First and Second Set of Requests for Production (Nos. 1-32) filed by Takeda Pharmaceuticals U.S.A., Inc..(Attaway, Daniel) (Entered: 03/31/2017)
2017-03-31
1
SUBPOENA filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation directed to Third-Party Subpoena for the Production of Documents to Prasco, LLC d/b/a Prasco Laboratories for April 24, 2017 (Attachments: # 1 Exhibit 1)(Gattuso, Dominick) (Entered: 04/03/2017)
2017-04-03
1
NOTICE OF SERVICE of Defendants' Objections and Responses to Plaintiffs First Set of Interrogatories (Nos. 1-20); and Defendants' Objections and Responses to Plaintiff's First Set of Requests for Production of Documents and Things (Nos. 1-26) filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.(Gattuso, Dominick) (Entered: 04/03/2017)
2017-04-03
1
Oral Order
2017-04-04
1
No Actions
ORAL ORDER re 153 Order Setting Teleconference - IT IS HEREBY ORDERED that the Initial ADR Teleconference scheduled for 4/5/2017 at 3:00 p.m. is CANCELLED and will be rescheduled at a later date. Signed by Judge Sherry R. Fallon on 4/4/2017. (Polito, Rebecca)
2017-04-04
1
No Actions
NOTICE of Third Party Subpoena of OptumRx, Inc. for the Production of Documents by Takeda Pharmaceuticals U.S.A., Inc. (Attachments: # 1 Exhibit 1)(Attaway, Daniel) (Entered: 04/06/2017)
2017-04-06
1
Oral Order
2017-04-07
1
No Actions
ORAL ORDER re 153 Order Setting Teleconference - IT IS HEREBY ORDERED that the Initial ADR Teleconference originally scheduled for 4/5/2017 at 3:00 p.m. is RESCHEDULED to October 2, 2017 at 10:00 a.m. Signed by Judge Sherry R. Fallon on 4/7/2017. (Polito, Rebecca)
2017-04-07
1
No Actions
NOTICE OF SERVICE of Plaintiff's Second Amended Initial Disclosures filed by Takeda Pharmaceuticals U.S.A., Inc..(Attaway, Daniel) (Entered: 04/13/2017)
2017-04-13
1
SUBPOENA filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation directed to Dr. Elmahdi M. Saeed for the Production of Documents (Attachments: # 1 Exhibit 1)(Gattuso, Dominick) (Entered: 04/21/2017)
2017-04-21
1
SUBPOENA filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation directed to Dr. Elmahdi M. Saeed to Testify at a Deposition for May 12, 2017 (Attachments: # 1 Exhibit 1)(Gattuso, Dominick) (Entered: 04/21/2017)
2017-04-21
1
NOTICE OF SERVICE of Plaintiff's Third Amended Initial Disclosures filed by Takeda Pharmaceuticals U.S.A., Inc..(Attaway, Daniel) (Entered: 04/25/2017)
2017-04-25
1
SUBPOENA filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation directed to Jillian Ross (Attachments: # 1 Exhibit 1)(Gattuso, Dominick) (Entered: 05/03/2017)
2017-05-03
1
NOTICE OF SERVICE of Plaintiff's Second Set of Requests for Production to West-Ward Pharmaceutical Corporation, Hikma Americas Inc., and Hikma Pharmaceuticals PLC (No. 27) filed by Takeda Pharmaceuticals U.S.A., Inc..(Attaway, Daniel) (Entered: 05/08/2017)
2017-05-08
1
MOTION for Order to Show Cause Why The Judgment for Defendants Should Not Be Reinstated - filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Text of Proposed Order)(Gattuso, Dominick) Modified on 5/11/2017 (lih). (Entered: 05/08/2017)
2017-05-08
1
[SEALED] OPENING BRIEF in Support re 193 MOTION for Order to Show Cause Why The Judgment for Defendants Should Not Be Reinstated filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.Answering Brief/Response due date per Local Rules is 5/22/2017. (Attachments: # 1 Certificate of Service)(Gattuso, Dominick) Modified on 5/11/2017 (lih). (Entered: 05/08/2017)
2017-05-08
1
[SEALED] DECLARATION re 193 MOTION for Order to Show Cause Why The Judgment for Defendants Should Not Be Reinstated by West-Ward Pharmaceutical Corporation. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Certificate of Service)(Gattuso, Dominick) Modified on 5/11/2017 (lih). (Entered: 05/08/2017)
2017-05-08
1
NOTICE of Withdrawal of Certain Pro Hac Vice Counsel by Takeda Pharmaceuticals U.S.A., Inc. (Attaway, Daniel) (Entered: 05/15/2017)
2017-05-15
1
REDACTED VERSION of 194 Opening Brief in Support, by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) (Entered: 05/15/2017)
2017-05-15
1
REDACTED VERSION of 195 Declaration by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N)(Gattuso, Dominick) Modified on 5/17/2017 (lih). (Entered: 05/15/2017)
2017-05-15
1
NOTICE of Withdrawal of Certain Pro Hac Vice Counsel by Takeda Pharmaceuticals U.S.A., Inc. (Attaway, Daniel) (Entered: 05/16/2017)
2017-05-16
1
Letter to The Honorable Sue L. Robinson from Dominick T. Gattuso regarding May 23, 2017 Status Conference. (Gattuso, Dominick) (Entered: 05/19/2017)
2017-05-19
1
ANSWERING BRIEF in Opposition re 193 MOTION for Order to Show Cause Why The Judgment for Defendants Should Not Be Reinstated filed by Takeda Pharmaceuticals U.S.A., Inc..Reply Brief due date per Local Rules is 5/26/2017. (Bourke, Mary) Modified on 5/22/2017 (lih). (Entered: 05/19/2017)
2017-05-19
1
[SEALED] DECLARATION re 201 Answering Brief in Opposition, by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G)(Bourke, Mary) (Entered: 05/19/2017)
2017-05-19
1
REPLY BRIEF re 193 MOTION for Order to Show Cause Why The Judgment for Defendants Should Not Be Reinstated filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) Modified on 5/23/2017 (lih). (Entered: 05/22/2017)
2017-05-22
1
Oral Order
2017-05-23
1
No Actions
Status Conference
2017-05-23
1
No Actions
Minute Entry for proceedings held before Judge Sue L. Robinson - In-Person Status Conference held on 5/23/2017. (Court Reporter V. Gunning.) (nmfn)
2017-05-23
1
No Actions
ORAL ORDER in court on 5/23/2017 denying 193 MOTION for Order to Show Cause Why The Judgment for Defendants Should Not Be Reinstated filed by West-Ward Pharmaceutical Corporation, Hikma Pharmaceuticals PLC, Hikma Americas Inc. Signed by Judge Sue L. Robinson on 5/23/2017. (nmfn, )
2017-05-23
1
No Actions
NOTICE of Third Party Subpoena of Dr. Elmahdi M. Saeed to Testify at a Deposition by Takeda Pharmaceuticals U.S.A., Inc. (Attachments: # 1 Exhibit 1)(Attaway, Daniel) (Entered: 05/25/2017)
2017-05-25
1
NOTICE of Third Party Subpoena of Dr. Rodolfo M. Garcia to Testify at a Deposition by Takeda Pharmaceuticals U.S.A., Inc. (Attachments: # 1 Exhibit 1)(Attaway, Daniel) (Entered: 05/25/2017)
2017-05-25
1
REDACTED VERSION of 202 Declaration, by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G)(Bourke, Mary) (Entered: 05/26/2017)
2017-05-26
1
Letter to The Honorable Sue L. Robinson from Mary W. Bourke regarding document discovery. (Attachments: # 1 Exhibit A)(Bourke, Mary) (Entered: 05/26/2017)
2017-05-26
1
NOTICE OF SERVICE of Defendants' Third Set of Requests for Production of Documents and Things (NOS 33-48) filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.(Gattuso, Dominick) (Entered: 05/30/2017)
2017-05-30
1
[SEALED] Letter to The Honorable Sue L. Robinson from Dominick T. Gattuso regarding Discovery. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Gattuso, Dominick) (Entered: 05/31/2017)
2017-05-31
1
NOTICE OF SERVICE of Plaintiff's Third Set of Requests for Production to West-Ward Pharmaceutical Corporation, Hikma Americas Inc., and Hikma Pharmaceuticals PLC (No. 28) filed by Takeda Pharmaceuticals U.S.A., Inc..(Attaway, Daniel) (Entered: 05/31/2017)
2017-05-31
1
NOTICE OF SERVICE of Defendants' Objections and Responses to Plaintiff's Second Set of Requests for Production of Documents and Things (No. 27) filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.(Gattuso, Dominick) (Entered: 06/01/2017)
2017-06-01
1
(VACATED - PER THE SO ORDERED OF D.I. 218 ) ORDER re 207 Letter, 209 Letter. IT IS ORDERED that the more limited discovery described by defendants is the more reasonable approach. SEE ORDER FOR FURTHER DETAILS. Signed by Judge Sue L. Robinson on 6/2/2017. (nmfn) Modified on 6/23/2017 (fms). (Entered: 06/02/2017)
2017-06-02
1
REDACTED VERSION of 209 Letter by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Gattuso, Dominick) Modified on 6/12/2017 (lih). (Entered: 06/05/2017)
2017-06-05
1
MOTION for Reargument re 212 Order Limiting Discovery - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Bourke, Mary) Modified on 6/12/2017 (lih). (Entered: 06/09/2017)
2017-06-09
1
[SEALED] DECLARATION re 214 MOTION for Reargument re 212 Order by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Bourke, Mary) Modified on 6/12/2017 (lih). (Entered: 06/09/2017)
2017-06-09
1
NOTICE OF SERVICE of Defendants' Amended Rule 26(a)(1) Initial Disclosures filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.(Gattuso, Dominick) (Entered: 06/12/2017)
2017-06-12
1
REDACTED VERSION of 215 Declaration by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Bourke, Mary) (Entered: 06/12/2017)
2017-06-12
1
STIPULATION re 212 Order by Takeda Pharmaceuticals U.S.A., Inc.. (Attaway, Daniel) (Entered: 06/22/2017)
2017-06-22
1
SO ORDERED
2017-06-23
1
No Actions
SO ORDERED, re 218 Stipulation. The Courts June 2, 2017 Order limiting discovery [D.I. 212 ] is VACATED. Denying without prejudice 214 MOTION for Reargument re 212 Order Plaintiff Takeda Pharmaceuticals U.S.A., Inc.'s Motion for Reargument of the Court' s June 2, 2017 Order Limiting Discovery filed by Takeda Pharmaceuticals U.S.A., Inc. See stipulation for further details and deadlines. Signed by Judge Sue L. Robinson on 6/23/2017. (fms)
2017-06-23
1
No Actions
NOTICE of Third Party Subpoena of Jimmy Ballard to Testify at a Deposition by Takeda Pharmaceuticals U.S.A., Inc. (Attachments: # 1 Exhibit 1)(Attaway, Daniel) (Entered: 06/26/2017)
2017-06-26
1
NOTICE of Subpoena of Dr. Yulanda Harrison to Testify at a Deposition by Takeda Pharmaceuticals U.S.A., Inc. (Attachments: # 1 Exhibit 1)(Attaway, Daniel) (Entered: 06/26/2017)
2017-06-26
1
NOTICE OF SERVICE of Plaintiff's Response to Defendants' Third Set of Requests for Production of Documents and Things (Nos. 33-48) filed by Takeda Pharmaceuticals U.S.A., Inc..(Attaway, Daniel) (Entered: 06/29/2017)
2017-06-29
1
NOTICE OF SERVICE of Defendants' Objections and Responses to Plaintiff's Third Set of Requests for Production of Documents and Things (No. 28) filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.(Gattuso, Dominick) (Entered: 06/30/2017)
2017-06-30
1
Case Assigned/Reassigned
2017-07-25
1
No Actions
Case Reassigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)
2017-07-25
1
No Actions
ORAL ORDER: In light of the recent reassignment of this matter the parties shall file a joint status letter within five days of the date of this Order. Ordered by Judge Richard G. Andrews on 7/26/2017. (nms) (Entered: 07/26/2017)
2017-07-26
1
Oral Order
2017-07-26
1
No Actions
Letter to The Honorable Richard G. Andrews from Dominick T. Gattuso regarding request for an extension of the due date for submission of the Joint Status Letter. (Gattuso, Dominick) (Entered: 07/27/2017)
2017-07-27
1
ORAL ORDER: The request for an extension of time (D.I. 224 ) is GRANTED. Ordered by Judge Richard G. Andrews on 7/28/2017. (nms) (Entered: 07/28/2017)
2017-07-28
1
Oral Order
2017-07-28
1
No Actions
MOTION for Pro Hac Vice Appearance of Attorney Sharick Naqi - filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) (Entered: 08/01/2017)
2017-08-01
1
SO ORDERED
2017-08-01
1
No Actions
SO ORDERED, re 226 MOTION for Pro Hac Vice Appearance of Attorney Sharick Naqi, filed by West-Ward Pharmaceutical Corporation, Hikma Pharmaceuticals PLC, Hikma Americas Inc.. Signed by Judge Richard G. Andrews on 8/1/2017. (nms)
2017-08-01
1
No Actions
Letter to Judge Andrews from Mary Bourke regarding Joint Status Report. (Bourke, Mary) Modified on 8/8/2017 (nms). (Entered: 08/04/2017)
2017-08-04
1
STIPULATION TO EXTEND TIME - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Bourke, Mary) Modified on 8/8/2017 (nms). (Entered: 08/04/2017)
2017-08-04
1
SO ORDERED
2017-08-08
1
No Actions
SO ORDERED, re 228 STIPULATION To Extend Scheduling Order deadlines. Signed by Judge Richard G. Andrews on 8/7/2017. (nms)
2017-08-08
1
No Actions
NOTICE OF SERVICE of Defendants' Objections and Responses to Plaintiff's First Set of Requests for Production of Documents and Things (Nos. 1-26) filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.(Gattuso, Dominick) (Entered: 08/17/2017)
2017-08-17
1
NOTICE OF SERVICE of Defendants' Second Set of Interrogatories to Plaintiff (Nos. 3-16) filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.(Gattuso, Dominick) (Entered: 09/01/2017)
2017-09-01
1
NOTICE to Take Deposition of Takeda Pharmaceuticals U.S.A., Inc. Pursuant to Fed. R. Civ. P. 30(b)(6) on October 10, 2017 filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.(Gattuso, Dominick) (Entered: 09/12/2017)
2017-09-12
1
NOTICE of Third Party Subpoena of Prasco Laboratories to Testify at a Deposition by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation (Attachments: # 1 Exhibit 1)(Gattuso, Dominick) (Entered: 09/12/2017)
2017-09-12
1
NOTICE to Take Deposition of Evelyn Hernandez on October 17, 2017 filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.(Gattuso, Dominick) (Entered: 09/13/2017)
2017-09-13
1
NOTICE to Take Deposition of Brian Moore on October 16, 2017 filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.(Gattuso, Dominick) (Entered: 09/13/2017)
2017-09-13
1
NOTICE to Take Deposition of Matthew Woods on October 13, 2017 filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.(Gattuso, Dominick) (Entered: 09/13/2017)
2017-09-13
1
NOTICE OF SERVICE of Plaintiff's Second Set of Interrogatories to West-Ward Pharmaceutical Corporation, Hikma Americas Inc., and Hikma Pharmaceuticals PLC (Nos. 21-25) filed by Takeda Pharmaceuticals U.S.A., Inc..(Attaway, Daniel) (Entered: 09/14/2017)
2017-09-14
1
MOTION for Pro Hac Vice Appearance of Attorney Lana S. Shiferman, Robyn R. Schwartz and Louis L. Lobel - filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) (Entered: 09/15/2017)
2017-09-15
1
NOTICE OF SERVICE of Plaintiff's Notice of Deposition of West-Ward Pharmaceutical Corporation, Hikma Americas Inc., and Hikma Pharmaceuticals PLC filed by Takeda Pharmaceuticals U.S.A., Inc..(Attaway, Daniel) (Entered: 09/18/2017)
2017-09-18
1
SO ORDERED
2017-09-18
1
No Actions
SO ORDERED, re 237 MOTION for Pro Hac Vice Appearance of Attorney Lana S. Shiferman, Robyn R. Schwartz and Louis L. Lobel, filed by West-Ward Pharmaceutical Corporation, Hikma Pharmaceuticals PLC, Hikma Americas Inc.. Signed by Judge Richard G. Andrews on 9/18/2017. (nms)
2017-09-18
1
No Actions
NOTICE to Take Deposition of Christopher Bonny on October 23, 2017 filed by Takeda Pharmaceuticals U.S.A., Inc..(Bourke, Mary) (Entered: 09/20/2017)
2017-09-20
1
NOTICE to Take Deposition of Doug Statler on October 20, 2017 filed by Takeda Pharmaceuticals U.S.A., Inc..(Bourke, Mary) (Entered: 09/20/2017)
2017-09-20
1
NOTICE to Take Deposition of Joel Rosenstack on October 19, 2017 filed by Takeda Pharmaceuticals U.S.A., Inc..(Bourke, Mary) (Entered: 09/20/2017)
2017-09-20
1
NOTICE to Take Deposition of Spiro Gavaris on October 18, 2017 filed by Takeda Pharmaceuticals U.S.A., Inc..(Bourke, Mary) (Entered: 09/20/2017)
2017-09-20
1
MOTION for Pro Hac Vice Appearance of Attorney Peter A. Detre - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attaway, Daniel) (Entered: 09/20/2017)
2017-09-20
1
Add Attorneys - PHV only
2017-09-21
1
No Actions
SO ORDERED
2017-09-21
1
No Actions
Pro Hac Vice Attorney Sharick Naqi for West-Ward Pharmaceutical Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm)
2017-09-21
1
No Actions
SO ORDERED, re 243 MOTION for Pro Hac Vice Appearance of Attorney Peter A. Detre, filed by Takeda Pharmaceuticals U.S.A., Inc.. Signed by Judge Richard G. Andrews on 9/21/2017. (nms)
2017-09-21
1
No Actions
Pro Hac Vice Attorney Peter A. Detre for Takeda Pharmaceuticals U.S.A., Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm)
2017-09-21
1
No Actions
NOTICE OF SERVICE of Plaintiff's Response to Defendants' First Notice of Rule 30(b)(6) Deposition of Takeda Pharmaceuticals U.S.A., Inc. filed by Takeda Pharmaceuticals U.S.A., Inc..(Attaway, Daniel) (Entered: 09/26/2017)
2017-09-26
1
Add Attorneys - PHV only
2017-09-26
1
No Actions
Pro Hac Vice Attorney Lana S. Shiferman,Louis L. Lobel,Robyn R. Schwartz for West-Ward Pharmaceutical Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm)
2017-09-26
1
No Actions
NOTICE OF SERVICE of (i) Defendants' First Set of Requests for Admission (Nos. 1-3); and (ii) Defendants' Third Set of Interrogatories to Plaintiff (Nos. 17-25) filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.(Gattuso, Dominick) (Entered: 09/29/2017)
2017-09-29
1
1 - Terminate Deadlines and Hearings AND Oral Order AND ~Util - Set Hearings
2017-09-29
1
No Actions
ORAL ORDER- Pursuant to the request of counsel, IT IS HEREBY ORDERED that: the teleconference set in this matter for 10/2/2017 is RESCHEDULED 1/22/2018 at 11:00 AM before Judge Sherry R. Fallon. Counsel for the plaintiff shall initiate the call to 302-573-4557. Ordered by Judge Sherry R. Fallon on 9/29/2017. (lih)
2017-09-29
1
No Actions
NOTICE OF SERVICE of Plaintiff's First Set of Requests for Admission to West-Ward Pharmaceutical Corporation, Hikma Americas Inc., and Hikma Pharmaceuticals PLC (Nos. 1-36) filed by Takeda Pharmaceuticals U.S.A., Inc..(Attaway, Daniel) (Entered: 10/02/2017)
2017-10-02
1
NOTICE OF SERVICE of Plaintiff's Responses to Defendants' Second Set of Joint Interrogatories (Nos. 3-16) filed by Takeda Pharmaceuticals U.S.A., Inc..(Attaway, Daniel) (Entered: 10/02/2017)
2017-10-02
1
NOTICE OF SERVICE of Defendants' Supplemental Objections and Responses to Plaintiff's First Set of Interrogatories (Nos. 1-20) [HIGHLY CONFIDENTIAL-SUBJECT TO PROTECTIVE ORDER] filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.(Gattuso, Dominick) (Entered: 10/06/2017)
2017-10-06
1
NOTICE OF SERVICE of Defendants' Objections and Responses to Plaintiff's Notice of Deposition of West-Ward Pharmaceutical Corporation, Hikma Americas Inc., and Hikma Pharmaceuticals PLC filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.(Gattuso, Dominick) (Entered: 10/12/2017)
2017-10-12
1
STIPULATION TO EXTEND TIME for certain Scheduling Order deadlines to see Stipulation - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Bourke, Mary) (Entered: 10/12/2017)
2017-10-12
1
SO ORDERED AND ~Util - Set Deadlines
2017-10-13
1
No Actions
SO ORDERED, re 250 STIPULATION TO EXTEND TIME for certain Scheduling Order deadlines. Signed by Judge Richard G. Andrews on 10/13/2017. (nms)
2017-10-13
1
No Actions
NOTICE OF SERVICE of Defendants' Objections and Responses to Plaintiff's Second Set of Interrogatories (Nos. 21-25) [HIGHLY CONFIDENTIAL SUBJECT TO PROTECTIVE ORDER] filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.(Gattuso, Dominick) (Entered: 10/16/2017)
2017-10-16
1
NOTICE OF SERVICE of Defendants' Second Supplemental Objections and Responses to Plaintiff's Interrogatory Nos. 5 & 22 [HIGHLY CONFIDENTIAL SUBJECT TO PROTECTIVE ORDER] filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.(Gattuso, Dominick) (Entered: 10/24/2017)
2017-10-24
1
NOTICE OF SERVICE of (1) Plaintiff's Responses to Defendants' First Set of Requests for Admission (Nos. 1-3) and (2) Plaintiff's Responses to Defendants' Third Set of Joint Interrogatories (Nos. 17-25) filed by Takeda Pharmaceuticals U.S.A., Inc..(Attaway, Daniel) (Entered: 10/30/2017)
2017-10-30
1
NOTICE OF SERVICE of Defendants' Objections and Responses to Plaintiff's First Set of Requests for Admission (Nos. 1-36) [HIGHLY CONFIDENTIAL SUBJECT TO PROTECTIVE ORDER] filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.(Gattuso, Dominick) (Entered: 10/30/2017)
2017-10-30
1
NOTICE OF SERVICE of Defendants' Second Set of Requests for Admission (Nos. 4-44) filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.(Gattuso, Dominick) (Main Document 255 replaced on 11/1/2017) (ksr, ). Modified on 11/1/2017 (ksr, ). (Entered: 10/31/2017)
2017-10-31
1
NOTICE of Third Party Subpoena of Anna Nazareno to Testify at a Deposition by Takeda Pharmaceuticals U.S.A., Inc. (Attachments: # 1 Exhibit 1)(Attaway, Daniel) (Entered: 10/31/2017)
2017-10-31
1
NOTICE of Third Party Subpoena of Daniel Bloor to Testify at a Deposition by Takeda Pharmaceuticals U.S.A., Inc. (Attachments: # 1 Exhibit 1)(Attaway, Daniel) (Entered: 10/31/2017)
2017-10-31
1
NOTICE of Third Party Subpoena of Kerry Burke to Testify at a Deposition by Takeda Pharmaceuticals U.S.A., Inc. (Attachments: # 1 Exhibit 1)(Attaway, Daniel) (Entered: 10/31/2017)
2017-10-31
1
NOTICE of Third Party Subpoena of Krishna Saunders to Testify at a Deposition by Takeda Pharmaceuticals U.S.A., Inc. (Attachments: # 1 Exhibit 1)(Attaway, Daniel) (Entered: 10/31/2017)
2017-10-31
1
NOTICE of Third Party Subpoena of Lisa Pendergrast to Testify at a Deposition by Takeda Pharmaceuticals U.S.A., Inc. (Attachments: # 1 Exhibit 1)(Attaway, Daniel) (Entered: 10/31/2017)
2017-10-31
1
NOTICE of Firm Name Change by Takeda Pharmaceuticals U.S.A., Inc. (Bourke, Mary) (Entered: 11/01/2017)
2017-11-01
1
NOTICE OF SERVICE of Plaintiff's First Supplemental Responses to Defendants' Second Set of Joint Interrogatories (Nos. 3-16) filed by Takeda Pharmaceuticals U.S.A., Inc..(Attaway, Daniel) (Entered: 11/01/2017)
2017-11-01
1
- CORRECTING ENTRY
2017-11-01
1
No Actions
CORRECTING ENTRY: Pursuant to Counsel's request, the PDF of D.I. 255 has been replaced with the corrected version of the filing. (ksr, )
2017-11-01
1
No Actions
NOTICE to Take Deposition of Don Blaha on November 16, 2017 filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.(Gattuso, Dominick) (Entered: 11/02/2017)
2017-11-02
1
NOTICE to Take Deposition of Dave Yamauchi on November 15, 2017 filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.(Gattuso, Dominick) (Entered: 11/02/2017)
2017-11-02
1
NOTICE OF SERVICE of Plaintiff's Second Supplemental Responses to Defendants' Second Set of Joint Interrogatories (Nos. 3-16) filed by Takeda Pharmaceuticals U.S.A., Inc..(Attaway, Daniel) (Entered: 11/06/2017)
2017-11-06
1
NOTICE OF SERVICE of Defendants' Supplemental Objections and Responses to Plaintiff's Interrogatory Nos. 20, 21, 23 [HIGHLY CONFIDENTIAL - SUBJECT TO PROTECTIVE ORDER] filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.(Gattuso, Dominick) (Entered: 11/17/2017)
2017-11-17
1
NOTICE of Third Party Subpoena of Kerry Burke To Testify at a Deposition by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation (Attachments: # 1 Exhibit A)(Gattuso, Dominick) (Entered: 11/21/2017)
2017-11-21
1
NOTICE of Third Party Subpoena of Anna Nazareno To Testify at a Deposition by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation (Attachments: # 1 Exhibit A)(Gattuso, Dominick) (Entered: 11/21/2017)
2017-11-21
1
NOTICE of Third Party Subpoena of Lisa Pendergrast To Testify at a Deposition by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation (Attachments: # 1 Exhibit A)(Gattuso, Dominick) (Entered: 11/21/2017)
2017-11-21
1
NOTICE of Third Party Subpoena of Krishna Saunders To Testify at a Deposition by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation (Attachments: # 1 Exhibit A)(Gattuso, Dominick) (Entered: 11/21/2017)
2017-11-21
1
STIPULATION TO EXTEND TIME Scheduling Order to - filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) (Entered: 11/30/2017)
2017-11-30
1
NOTICE OF SERVICE of (1) Plaintiff's First Supplemental Responses to Defendants' First Set of Joint Interrogatories (Nos. 1-2); (2) Plaintiff's Third Supplemental Responses to Defendants' Second Set of Joint Interrogatories (Nos. 3-16); (3) Plaintiff's First Supplemental Responses to Defendants' Third Set of Interrogatories to Plaintiff (Nos. 17-25); (4) Plaintiff's Fourth Amended Initial Disclosures, and (5) Plaintiff's Responses to Defendants' Second Set of Requests for Admission (Nos. 4-44) filed by Takeda Pharmaceuticals U.S.A., Inc..(Attaway, Daniel) (Entered: 11/30/2017)
2017-11-30
1
SO ORDERED
2017-12-01
1
No Actions
SO ORDERED, re 271 STIPULATION and Order to Extend Time. Signed by Judge Richard G. Andrews on 12/1/2017. (nms)
2017-12-01
1
No Actions
STIPULATION and Proposed Order Permitting Par to Intervene, by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) Modified on 12/5/2017 (nms). (Entered: 12/04/2017)
2017-12-04
1
SO ORDERED, Granting 273 Stipulation and Order Permitting Par to Intervene. Signed by Judge Richard G. Andrews on 12/5/2017. (nms) (Entered: 12/05/2017)
2017-12-05
1
MOTION for Pro Hac Vice Appearance of Attorney Richard J. Berman, Janine A. Carlan and Bradford Frese - filed by Par Pharmaceutical, Inc.. (Fineman, Steven) (Entered: 12/06/2017)
2017-12-06
1
SO ORDERED
2017-12-06
1
No Actions
SO ORDERED, re 275 MOTION for Pro Hac Vice Appearance of Attorney Richard J. Berman, Janine A. Carlan and Bradford Frese, filed by Par Pharmaceutical, Inc.. Signed by Judge Richard G. Andrews on 12/6/2017. (nms)
2017-12-06
1
No Actions
Add Attorneys - PHV only
2017-12-07
1
No Actions
Pro Hac Vice Attorney Bradford C. Frese, Janine A. Carlan and Richard J. Berman for Par Pharmaceutical, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (nmg)
2017-12-07
1
No Actions
NOTICE OF SERVICE of 1) Defendants' Supplemental Objections and Responses to Plaintiff's Interrogatory Nos. 8, 10-12, 19, 21 & 23 [HIGHLY CONFIDENTIAL - SUBJECT TO PROTECTIVE ORDER]; and 2) Defendants' Second Amended Rule 26(a)(1) Initial Disclosures filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.(Gattuso, Dominick) (Entered: 12/08/2017)
2017-12-08
1
NOTICE OF SERVICE of (1) Plaintiff's Second Supplemental Responses to Defendants' First Set of Joint Interrogatories (Nos. 1-2); (2) Plaintiff's Fourth Supplemental Responses to Defendants' Second Set of Joint Interrogatories (Nos. 3-16), and (3) Plaintiff's Second Supplemental Responses to Defendants' Third Set of Interrogatories to Plaintiff (Nos.17-25) filed by Takeda Pharmaceuticals U.S.A., Inc..(Attaway, Daniel) (Entered: 12/11/2017)
2017-12-11
1
STIPULATION and Order Amending Scheduling Order - filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) Modified on 12/28/2017 (nms). (Entered: 12/26/2017)
2017-12-26
1
SO ORDERED
2017-12-28
1
No Actions
SO ORDERED, re 278 STIPULATION and Order Amending Scheduling Order. Signed by Judge Richard G. Andrews on 12/28/2017. (nms)
2017-12-28
1
No Actions
NOTICE to Take Deposition of Mike Brumfield on January 12, 2018 filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.(Gattuso, Dominick) (Entered: 01/04/2018)
2018-01-04
1
NOTICE of Third Party Subpoenas to Testify at a Deposition by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Gattuso, Dominick) (Entered: 01/05/2018)
2018-01-05
1
NOTICE to Take Deposition of Prasco Laboratories on January 12, 2018 filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.(Gattuso, Dominick) (Entered: 01/08/2018)
2018-01-08
1
NOTICE of Third Party Subpoena of inVentiv Health, Inc. for the Production of Documents by Takeda Pharmaceuticals U.S.A., Inc. (Attachments: # 1 Exhibit A)(Bourke, Mary) (Entered: 01/10/2018)
2018-01-10
1
NOTICE of Subpoena of Michael Reedy to Testify at a Deposition by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation (Attachments: # 1 Exhibit A)(Gattuso, Dominick) (Entered: 01/10/2018)
2018-01-10
1
Joint MOTION for Teleconference to Resolve Discovery Dispute - filed by Takeda Pharmaceuticals U.S.A., Inc.. Motions referred to Sherry R. Fallon.(Bourke, Mary) Modified on 1/12/2018 (lih). (Entered: 01/12/2018)
2018-01-12
1
NOTICE of of Third Party Subpoena of Prasco Laboratories to Testify at a Deposition by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation (Attachments: # 1 Subpoena)(Gattuso, Dominick) (Entered: 01/16/2018)
2018-01-16
1
[SEALED] Letter to The Honorable Magistrate Judge Fallon from Mary W. Bourke regarding discovery dispute. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Bourke, Mary) Modified on 1/16/2018 (lih). (Entered: 01/16/2018)
2018-01-16
1
SO ORDERED AND ~Util - Set Hearings
2018-01-16
1
No Actions
SO ORDERED- re 284 Joint MOTION for Teleconference to Resolve Discovery Dispute. A Telephone Conference is set for 1/22/2018 at 011:00 AM before Judge Sherry R. Fallon. Counsel for the plaintiff shall initiate the call to 302-573-4557. In preparation for this hearing the parties shall follow the Discovery Matters and Disputes procedure as set forth in the Order regarding discovery matters available at www.ded.uscourts.gov/judge/magistrate-judge-sherry-r-fallon. Set Deadlines: (Moving Submission due by no later than 11:00 AM today, Responsive submission due by no later than 11:00 AM on 1/17/2018.) Signed by Judge Sherry R. Fallon on 1/12/2018. (lih)
2018-01-16
1
No Actions
Oral Order
2018-01-17
1
No Actions
ORAL ORDER- re 284 Joint MOTION Teleconference to Resolve Discovery Dispute. Having been notified by counsel that the pending discovery dispute has been resolved, IT IS HEREBY ORDERED that: the discovery dispute teleconference set for 1/22/2018 is CANCELLED. The court shall still conduct the ADR portion of the call as previously scheduled. Ordered by Judge Sherry R. Fallon on 1/17/2018. (lih)
2018-01-17
1
No Actions
REDACTED VERSION of 286 Letter, by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Bourke, Mary) (Entered: 01/23/2018)
2018-01-23
1
NOTICE OF SERVICE of Plaintiff's Third Set of Interrogatories to West-Ward Pharmaceutical Corporation, Hikma Americas Inc., and Hikma Pharmaceuticals PLC (No. 26) filed by Takeda Pharmaceuticals U.S.A., Inc..(Attaway, Daniel) (Entered: 01/30/2018)
2018-01-30
1
NOTICE OF SERVICE of 1) Expert Report of Sumanth Addanki, Ph.D. [HIGHLY CONFIDENTIAL]; Expert Report of Simon M. Helfgott, M.D.; 3) Expert Report of Sandra Kinsey [HIGHLY CONFIDENTIAL]; and 4) Expert Report of John S. Russell, M.S. filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.(Gattuso, Dominick) (Entered: 02/05/2018)
2018-02-05
1
1 - Terminate Hearings AND Oral Order AND ~Util - Set Hearings
2018-02-05
1
No Actions
ORAL ORDER- IT IS HEREBY ORDERED that: the teleconference previously set in this matter for 1/22/2018 is RESCHEDULED to 2/20/2018 at 03:00 PM before Judge Sherry R. Fallon. Counsel for the plaintiff shall initiate the call to 302-573-4557. Ordered by Judge Sherry R. Fallon on 2/5/2018. (lih)
2018-02-05
1
No Actions
NOTICE of Third Party Subpoena of Wal-Mart Stores, Inc. for the Production of Documents by Takeda Pharmaceuticals U.S.A., Inc. (Attaway, Daniel) (Entered: 02/15/2018)
2018-02-15
1
NOTICE of Third Party Subpoena of CVS Health for the Production of Documents by Takeda Pharmaceuticals U.S.A., Inc. (Attaway, Daniel) (Entered: 02/15/2018)
2018-02-15
1
Case Referred to Mediation - Magistrate Judge only
2018-02-22
1
No Actions
Order Referring Case to Mediation
2018-02-22
1
No Actions
Oral ORDER REFERRING CASE to Judge Thynge for Mediation. Ordered by Judge Sherry R. Fallon on 2/22/2018. (lih)
2018-02-22
1
No Actions
CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation (cak)
2018-02-22
1
No Actions
NOTICE of Third Party Subpoena of Kaiser Foundation Health Plan, Inc. for the Production of Documents by Takeda Pharmaceuticals U.S.A., Inc. (Attaway, Daniel) (Entered: 02/28/2018)
2018-02-28
1
NOTICE of Third Party Subpoena of Rite Aid Corporation for the Production of Documents by Takeda Pharmaceuticals U.S.A., Inc. (Attaway, Daniel) (Entered: 02/28/2018)
2018-02-28
1
NOTICE of Third Party Subpoena of The Walgreen Company a/k/a Walgreens for the Production of Documents by Takeda Pharmaceuticals U.S.A., Inc. (Attaway, Daniel) (Entered: 02/28/2018)
2018-02-28
1
NOTICE OF SERVICE of Defendants' Objections and Responses to Plaintiff's Third Set of Interrogatories (No. 26) [HIGHLY CONFIDENTIAL-SUBJECT TO PROTECTIVE ORDER] filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.(Gattuso, Dominick) (Entered: 03/01/2018)
2018-03-01
1
NOTICE OF SERVICE of Defendants' Supplemental Objections and Responses to Plaintiff's Interrogatory No. 19 [HIGHLY CONFIDENTIAL - SUBJECT TO PROTECTIVE ORDER] filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.(Gattuso, Dominick) (Entered: 03/06/2018)
2018-03-06
1
ORDER Setting Mediation Conferences: A Mediation Conference is set for 5/2/2018 at 10:00 AM in Courtroom 2B before Judge Mary Pat Thynge. SEE ORDER FOR DETAILS. Signed by Judge Mary Pat Thynge on 3/6/18. (cak) (Entered: 03/06/2018)
2018-03-06
1
NOTICE of Third Party Subpoena of Prasco, LLC d/b/a Prasco Laboratories to Testify at a Deposition by Takeda Pharmaceuticals U.S.A., Inc. (Attaway, Daniel) (Entered: 03/08/2018)
2018-03-08
1
NOTICE of Third Party Subpoena of Seth Morris to Testify at a Deposition by Takeda Pharmaceuticals U.S.A., Inc. (Attaway, Daniel) (Entered: 03/08/2018)
2018-03-08
1
NOTICE OF SERVICE of (1) Expert Rebuttal Report of Carla Mulhern; (2) Expert Report of Robert Navarro; (3) Rebuttal Expert Report of Allan H. Morton; (4) Rebuttal Expert Report of Harry C. Boghigian, and (5) Rebuttal Expert Report of Matthew R. Pike filed by Takeda Pharmaceuticals U.S.A., Inc..(Attaway, Daniel) (Entered: 03/09/2018)
2018-03-09
1
NOTICE of Subpoena Ad Testificandum and Duces Tecum to CVS Health by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation (Attachments: # 1 Exhibit 1)(Gattuso, Dominick) (Entered: 03/12/2018)
2018-03-12
1
NOTICE of Subpoena Ad Testificandum and Duces Tecum to the Kaiser Foundation Health Plan, Inc. by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation (Attachments: # 1 Exhibit 1)(Gattuso, Dominick) (Entered: 03/12/2018)
2018-03-12
1
NOTICE of Subpoena Ad Testificandum and Duces Tecum to Rite Aid Corporation by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation (Attachments: # 1 Exhibit 1)(Gattuso, Dominick) (Entered: 03/12/2018)
2018-03-12
1
NOTICE of Subpoena Ad Testificandum and Duces Tecum to the Walgreen Company by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation (Attachments: # 1 Exhibit 1)(Gattuso, Dominick) (Entered: 03/12/2018)
2018-03-12
1
NOTICE of Subpoena Ad Testificandum and Duces Tecum to Wal-Mart Stores, Inc. by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation (Attachments: # 1 Exhibit 1)(Gattuso, Dominick) (Entered: 03/12/2018)
2018-03-12
1
STIPULATION regarding third party discovery cutoff by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) (Entered: 03/12/2018)
2018-03-12
1
NOTICE of Subpoena Ad Testificandum to Seth Morris by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation (Attachments: # 1 Exhibit 1)(Gattuso, Dominick) (Entered: 03/12/2018)
2018-03-12
1
NOTICE of Third Party Subpoena of Prasco Laboratories to Testify at a Deposition by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation (Attachments: # 1 Exhibit 1)(Gattuso, Dominick) (Entered: 03/13/2018)
2018-03-13
1
SO ORDERED
2018-03-13
1
No Actions
SO ORDERED, re 306 Stipulation regarding third party discovery cutoff. Signed by Judge Richard G. Andrews on 3/13/2018. (nms)
2018-03-13
1
No Actions
NOTICE of Withdrawal of Pro Hac Attorney Sharick Naqi by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation (Gattuso, Dominick) (Entered: 03/16/2018)
2018-03-16
1
NOTICE OF SERVICE of Revised Expert Report of Robert Navarro filed by Takeda Pharmaceuticals U.S.A., Inc..(Attaway, Daniel) (Entered: 03/26/2018)
2018-03-26
1
NOTICE OF SERVICE of 1) Corrected Expert Report of John S. Russell, M.S., [HIGHLY CONFIDENTIAL - SUBJECT TO PROTECTIVE ORDER]; and 2) Supplemental Expert Report of Sandra Kinsey [HIGHLY CONFIDENTIAL] filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.(Gattuso, Dominick) (Entered: 03/26/2018)
2018-03-26
1
Joint MOTION for For Teleconference to Resolve Discovery Dispute - filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. Motions referred to Sherry R. Fallon.(Gattuso, Dominick) Modified on 3/27/2018 (lih). (Entered: 03/26/2018)
2018-03-26
1
SO ORDERED AND ~Util - Set Hearings
2018-03-27
1
No Actions
SO ORDERED- re 312 Joint MOTION for Teleconference to Resolve Discovery Dispute. A Telephone Conference is set for 4/11/2018 at 11:00 AM before Judge Sherry R. Fallon. Counsel for the Hikma defendants shall initiate the call to 302-573-4557. In preparation for this hearing the parties shall follow the Discovery Matters and Disputes procedure as set forth in the Order regarding discovery matters available at www.ded.uscourts.gov/judge/magistrate-judge-sherry-r-fallon. Set Deadlines: (Moving Submission due by no later than 3:00 PM on 4/5/2018, Responsive submission due by no later than 3:00 PM on 4/6/2018.) Signed by Judge Sherry R. Fallon on 3/27/2018. (lih)
2018-03-27
1
No Actions
[SEALED] Letter to The Honorable Sherry R. Fallon, from Dominick T. Gattuso, regarding Discovery Dispute. (Attachments: # 1 Exhibits A-G)(Gattuso, Dominick) Modified on 4/5/2018 (lih). Modified on 4/6/2018 (nms). (Entered: 04/05/2018)
2018-04-05
1
[SEALED] Letter to The Honorable Sherry R. Fallon from Daniel M. Attaway regarding discovery dispute - re 313 Letter. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Certificate of Service)(Attaway, Daniel) (Entered: 04/06/2018)
2018-04-06
1
NOTICE of Withdrawal of Certain Pro Hac Vice Counsel by Takeda Pharmaceuticals U.S.A., Inc. (Attaway, Daniel) (Entered: 04/09/2018)
2018-04-09
1
STIPULATION and [Proposed] Order for Leave of Court to Exceed Page Limit and to Amend Scheduling Order by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) (Entered: 04/10/2018)
2018-04-10
1
NOTICE of Appearance by Aaron M. Nelson on behalf of Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation (Nelson, Aaron) (Entered: 04/11/2018)
2018-04-11
1
Telephone Conference
2018-04-11
1
No Actions
SO ORDERED
2018-04-11
1
No Actions
Oral Order
2018-04-11
1
No Actions
SO ORDERED, re 316 Stipulation and Order for Leave of Court to Exceed Page Limit and to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 4/10/2018. (nms)
2018-04-11
1
No Actions
Minute Entry for proceedings held before Judge Sherry R. Fallon - Discovery Dispute Telephone Conference held on 4/11/2018. (Court Reporter S. Ingram (Hawkins Reporting).) (lih)
2018-04-11
1
No Actions
ORAL ORDER setting briefing schedule regarding the motion to strike supplemental interrogatory response. The opening submission, limited to no more than five pages, is due on or before 4/18/2018. The answering submission, limited to no more than five pages, is due on or before 4/25/2018. The parties are advised to be judicious in their selection of exhibits attached to the letter briefing. Ordered by Judge Sherry R. Fallon on 4/11/2018. (lih)
2018-04-11
1
No Actions
[SEALED] MEMORANDUM ORDER re 312 Joint MOTION for Discovery. Signed by Judge Sherry R. Fallon on 4/12/2018.This order has been emailed to local counsel. (lih) (Entered: 04/12/2018)
2018-04-12
1
REDACTED VERSION of 313 Letter, by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Exhibits A-G)(Gattuso, Dominick) Modified on 4/12/2018 (nms). (Entered: 04/12/2018)
2018-04-12
1
STIPULATION To Exclude Document Marked COLCRYS-WW0022740 and Withdraw Expert Report of Dr. Simon M. Helfgott by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) (Entered: 04/12/2018)
2018-04-12
1
NOTICE OF SERVICE of Defendants' Supplemental Objections and Responses to Plaintiff's Interrogatory No. 19 [HIGHLY CONFIDENTIAL - SUBJECT TO PROTECTIVE ORDER] filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.(Gattuso, Dominick) (Entered: 04/13/2018)
2018-04-13
1
REDACTED VERSION of 314 Letter by Takeda Pharmaceuticals U.S.A., Inc.. (Attaway, Daniel) (Entered: 04/13/2018)
2018-04-13
1
MOTION for Recovery of Damages on Bond - filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Proposed Order).(Gattuso, Dominick) Modified on 4/25/2018 (nms). (Entered: 04/13/2018)
2018-04-13
1
[SEALED] OPENING BRIEF in Support re 323 MOTION for Recovery of Damages on Bond filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.Answering Brief/Response due date per Local Rules is 4/27/2018. (Attachments: # 1 Certificate of Service)(Gattuso, Dominick) (Entered: 04/13/2018)
2018-04-13
1
[SEALED] DECLARATION of Dominick T. Gattuso, Volume 1 of 2 re 323 MOTION for Recovery of Damages on Bond, by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Exhibits 1-7, # 2 Certificate of Service)(Gattuso, Dominick) Modified on 4/16/2018 (nms). (Entered: 04/13/2018)
2018-04-13
1
[SEALED] DECLARATION of Dominick T. Gattuso, Volume 2 of 2 re 323 MOTION for Recovery of Damages on Bond, by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Exhibits 8-15, # 2 Exhibits 16-26, # 3 Exhibits 27-37, # 4 Exhibits 38-51, # 5 Certificate of Service)(Gattuso, Dominick) Modified on 4/16/2018 (nms). (Attachment 2 replaced on 5/17/2018) (nms). (Attachment 4 replaced on 5/17/2018) (nms). (Entered: 04/13/2018)
2018-04-13
1
SO ORDERED
2018-04-13
1
No Actions
SO ORDERED, re 320 Stipulation to Exclude Document Marked COLCRYS-WW0022740 and Withdraw Expert Report of Dr. Simon M. Helfgott. Signed by Judge Richard G. Andrews on 4/13/2018. (nms)
2018-04-13
1
No Actions
[SEALED] Letter to The Honorable Sherry R. Fallon from Daniel M. Attaway regarding Proposed Redacted Memorandum Order. (Attachments: # 1 Proposed Redacted Memorandum Order)(Attaway, Daniel) (Entered: 04/18/2018)
2018-04-18
1
[SEALED] Letter to Magistrate Judge Fallon from Daniel M. Attaway regarding Motion to Strike Hikma's Supplemental Interrogatory Response. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Certificate of Service)(Attaway, Daniel) (Entered: 04/18/2018)
2018-04-18
1
REDACTED VERSION of 324 Opening Brief in Support, by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) (Entered: 04/20/2018)
2018-04-20
1
REDACTED VERSION of 325 Declaration of Dominick T. Gattuso, Volume 1 of 2, by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Exhibits 1-7)(Gattuso, Dominick) Modified on 4/23/2018 (nms). (Entered: 04/20/2018)
2018-04-20
1
REDACTED VERSION of 326 Declaration of Dominick T. Gattuso, Volume 2 of 2, by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Exhibits 8-15, # 2 Exhibits 16-26, # 3 Exhibits 27-37, # 4 Exhibits 38-51)(Gattuso, Dominick) Modified on 4/23/2018 (nms). (Entered: 04/20/2018)
2018-04-20
1
REDACTED VERSION of 318 Memorandum Order. (lih) (Entered: 04/20/2018)
2018-04-20
1
REDACTED VERSION of 327 Letter by Takeda Pharmaceuticals U.S.A., Inc.. (Attaway, Daniel) (Entered: 04/25/2018)
2018-04-25
1
[SEALED] Letter to The Honorable Sherry R. Fallon re 328 [SEALED] Letter (Attachments: # 1 Exhibits A-M)(Gattuso, Dominick) Modified on 4/26/2018 (nms). Modified on 4/26/2018 (lih). (Entered: 04/25/2018)
2018-04-25
1
REDACTED VERSION of 328 Letter, by Takeda Pharmaceuticals U.S.A., Inc.. (Attaway, Daniel) (Entered: 04/25/2018)
2018-04-25
1
Motions No Longer Referred: 323 MOTION for Recovery of Damages on Bond. (nms)
2018-04-25
1
No Actions
NOTICE of Third Party Subpoena of Jonathan Lapps to Testify at a Deposition by Takeda Pharmaceuticals U.S.A., Inc. (Attachments: # 1 Exhibit 1)(Attaway, Daniel) (Entered: 04/27/2018)
2018-04-27
1
NOTICE of Third Party Subpoena of Prasco, LLC d/b/a Prasco Laboratories to Testify at a Deposition by Takeda Pharmaceuticals U.S.A., Inc. (Attachments: # 1 Exhibit 1)(Attaway, Daniel) (Entered: 04/27/2018)
2018-04-27
1
NOTICE of Third Party Subpoena of Jonathan Lapps to Testify at a Deposition by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation (Attachments: # 1 Exhibit A)(Gattuso, Dominick) (Entered: 04/27/2018)
2018-04-27
1
[SEALED] ANSWERING BRIEF in Opposition re 323 MOTION for Recovery of Damages on Bond filed by Takeda Pharmaceuticals U.S.A., Inc..Reply Brief due date per Local Rules is 5/4/2018. (Attachments: # 1 Certificate of Service)(Bourke, Mary) (Entered: 04/27/2018)
2018-04-27
1
[SEALED] DECLARATION of Matthew Woods re 339 Answering Brief in Opposition, by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Certificate of Service)(Bourke, Mary) Modified on 4/30/2018 (nms). (Entered: 04/27/2018)
2018-04-27
1
[SEALED] DECLARATION of Daniel M. Attaway re 339 Answering Brief in Opposition, by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Certificate of Service)(Attaway, Daniel) Modified on 4/30/2018 (nms). (Entered: 04/27/2018)
2018-04-27
1
[SEALED] DECLARATION of Daniel M. Attaway re 339 Answering Brief in Opposition, by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit 26, # 2 Exhibit 27, # 3 Exhibit 28, # 4 Exhibit 29, # 5 Exhibit 30, # 6 Exhibit 31, # 7 Exhibit 32, # 8 Exhibit 33, # 9 Exhibit 34, # 10 Exhibit 35, # 11 Exhibit 36, # 12 Exhibit 37, # 13 Exhibit 38, # 14 Exhibit 39, # 15 Exhibit 40, # 16 Exhibit 41, # 17 Exhibit 42, # 18 Certificate of Service)(Attaway, Daniel) Modified on 4/30/2018 (nms). (Entered: 04/27/2018)
2018-04-27
1
ORAL ORDER re 297 Order Setting Mediation Conferences: As a result of the Court's review of the mediation statements and separate discussions with counsel for the parties on Monday, April 30, 2018, the mediation scheduled for May 2, 2018 at 10:00 a.m. is postponed until resolution of recovery on the bond is decided. Counsel for defendants shall provide a copy of the decision to Chief Magistrate Judge Thynge and her Judicial Administrator, Cathleen Kennedy, which may be provided by email. Ordered by Judge Mary Pat Thynge on 5/1/18. (cak) (Entered: 05/01/2018)
2018-05-01
1
Unopposed MOTION to Withdraw - filed by Par Pharmaceutical, Inc.. (Attachments: # 1 Proposed Order)(Fineman, Steven) Modified on 5/2/2018 (nms). (Entered: 05/02/2018)
2018-05-02
1
ORDER Granting 344 Unopposed MOTION to Withdraw (*Party Par Pharmaceutical, Inc. terminated. Attorney Steven J. Fineman; Bradford C. Frese; Katharine Lester Mowery; Richard J. Berman and Janine A. Carlan terminated). Signed by Judge Richard G. Andrews on 5/2/2018. (nms) (Entered: 05/02/2018)
2018-05-02
1
REDACTED VERSION of 334 Letter, by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Exhibits A-M)(Gattuso, Dominick) Modified on 5/3/2018 (lih). (Entered: 05/02/2018)
2018-05-02
1
MOTION for Summary Judgment - filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Text of Proposed Order)(Gattuso, Dominick) (Entered: 05/04/2018)
2018-05-04
1
REDACTED VERSION of 339 Answering Brief in Opposition, by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Certificate of Service)(Attaway, Daniel) Modified on 5/7/2018 (nms). (Entered: 05/04/2018)
2018-05-04
1
[SEALED] OPENING BRIEF in Support re 347 MOTION for Summary Judgment filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation.Answering Brief/Response due date per Local Rules is 5/18/2018. (Attachments: # 1 Certificate of Service)(Gattuso, Dominick) (Entered: 05/04/2018)
2018-05-04
1
[SEALED] DECLARATION of Dominick T. Gattuso re 349 Opening Brief in Support, by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Exhibits 1-10, # 2 Exhibits 11-20, # 3 Exhibits 21-28, # 4 Certificate of Service)(Gattuso, Dominick) Modified on 5/7/2018 (nms). (Entered: 05/04/2018)
2018-05-04
1
REDACTED VERSION of 340 Declaration of Matthew Woods, by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Certificate of Service)(Attaway, Daniel) Modified on 5/7/2018 (nms). (Entered: 05/04/2018)
2018-05-04
1
REDACTED VERSION of 341 Declaration of Daniel M. Attaway, by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Certificate of Service)(Attaway, Daniel) Modified on 5/7/2018 (nms). (Entered: 05/04/2018)
2018-05-04
1
REDACTED VERSION of 342 Declaration of Daniel M. Attaway, by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit 26, # 2 Exhibit 27, # 3 Exhibit 28, # 4 Exhibit 29, # 5 Exhibit 30, # 6 Exhibit 31, # 7 Exhibit 32, # 8 Exhibit 33, # 9 Exhibit 34, # 10 Exhibit 35, # 11 Exhibit 36, # 12 Exhibit 37, # 13 Exhibit 38, # 14 Exhibit 39, # 15 Exhibit 40, # 16 Exhibit 41, # 17 Exhibit 42, # 18 Certificate of Service)(Attaway, Daniel) Modified on 5/7/2018 (nms). (Entered: 05/04/2018)
2018-05-04
1
[SEALED] REPLY BRIEF re 323 MOTION for Recovery of Damages on Bond filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Certificate of Service)(Gattuso, Dominick) (Entered: 05/04/2018)
2018-05-04
1
[SEALED] DECLARATION of Dominick T. Gattuso re 354 Reply Brief, by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Exhibits 52-60, # 2 Exhibits 61-74, # 3 Certificate of Service)(Gattuso, Dominick) Modified on 5/7/2018 (nms). (Entered: 05/04/2018)
2018-05-04
1
REDACTED VERSION of 354 Reply Brief, by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) (Entered: 05/10/2018)
2018-05-10
1
REDACTED VERSION of 355 Declaration of Dominick T. Gattuso, by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Exhibits 52-74)(Gattuso, Dominick) Modified on 5/10/2018 (nms). (Entered: 05/10/2018)
2018-05-10
1
REDACTED VERSION of 349 Opening Brief in Support, by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) (Entered: 05/11/2018)
2018-05-11
1
REDACTED VERSION of 350 Declaration of Dominick T. Gattuso, by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Exhibits 1-10, # 2 Exhibits 11-20, # 3 Exhibits 21-28)(Gattuso, Dominick) Modified on 5/14/2018 (nms). (Entered: 05/11/2018)
2018-05-11
1
REQUEST for Oral Argument by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation re 323 MOTION for Recovery of Damages on Bond . (Gattuso, Dominick) (Entered: 05/11/2018)
2018-05-11
1
CORRECTING ENTRY: The pdf for Exhibits 16-26 and the pdf for Exhibits 38-51 found at D.I. 326 has been replaced with amended versions per counsel's request. (nms)
2018-05-17
1
No Actions
[SEALED] ANSWERING BRIEF in Opposition re 347 MOTION for Summary Judgment filed by Takeda Pharmaceuticals U.S.A., Inc..Reply Brief due date per Local Rules is 5/25/2018. (Bourke, Mary) (Entered: 05/18/2018)
2018-05-18
1
[SEALED] DECLARATION of Daniel M. Attaway, Volume 1 re 361 Answering Brief in Opposition, by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25)(Attaway, Daniel) Modified on 5/21/2018 (nms). (Main Document 362 replaced on 5/24/2018) (nms). (Entered: 05/18/2018)
2018-05-18
1
[SEALED] DECLARATION of Daniel M. Attaway, Volume 2 re 361 Answering Brief in Opposition, by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit 26, # 2 Exhibit 27, # 3 Exhibit 28, # 4 Exhibit 29, # 5 Exhibit 30, # 6 Exhibit 31, # 7 Exhibit 32, # 8 Exhibit 33, # 9 Exhibit 34, # 10 Exhibit 35, # 11 Exhibit 36, # 12 Exhibit 37, # 13 Exhibit 38, # 14 Exhibit 39, # 15 Exhibit 40, # 16 Exhibit 41, # 17 Exhibit 42, # 18 Exhibit 43, # 19 Exhibit 44, # 20 Exhibit 45, # 21 Exhibit 46, # 22 Exhibit 47, # 23 Exhibit 48, # 24 Exhibit 49, # 25 Exhibit 50, # 26 Exhibit 51, # 27 Exhibit 52, # 28 Exhibit 53, # 29 Exhibit 54, # 30 Exhibit 55, # 31 Exhibit 56, # 32 Exhibit 57, # 33 Exhibit 58, # 34 Exhibit 59, # 35 Exhibit 60, # 36 Exhibit 61, # 37 Exhibit 62, # 38 Exhibit 63, # 39 Exhibit 64, # 40 Exhibit 65, # 41 Exhibit 66, # 42 Exhibit 67)(Attaway, Daniel) Modified on 5/21/2018 (nms). (Main Document 363 replaced on 5/24/2018) (nms). (Attachment 20 replaced on 6/13/2018) (nms). (Entered: 05/18/2018)
2018-05-18
1
Letter to The Honorable Richard G. Andrews, from Dominick T. Gattuso, enclosing CD with hyperlinks containing Defendants' briefing in support of Hikmas Motion to Recover Damages for Wrongful Restraint. (Gattuso, Dominick) Modified on 5/23/2018 (nms). (Entered: 05/22/2018)
2018-05-22
1
CORRECTING ENTRY: The main pdfs for D.I. 362 and 363 have been replaced with amended versions per counsel's request. (nms)
2018-05-24
1
No Actions
REDACTED VERSION of 361 Answering Brief in Opposition by Takeda Pharmaceuticals U.S.A., Inc.. (Attaway, Daniel) (Entered: 05/25/2018)
2018-05-25
1
REDACTED VERSION of 362 Declaration, by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibits 6-10, # 7 Exhibit 11, # 8 Exhibits 12-25)(Attaway, Daniel) Modified on 5/29/2018 (nms). (Entered: 05/25/2018)
2018-05-25
1
REDACTED VERSION of 363 Declaration, by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibits 26-41, # 2 Exhibit 42, # 3 Exhibit 43, # 4 Exhibit 44, # 5 Exhibit 45, # 6 Exhibit 46, # 7 Exhibit 47, # 8 Exhibits 48-63, # 9 Exhibit 64, # 10 Exhibit 65, # 11 Exhibit 66, # 12 Exhibit 67)(Attaway, Daniel) Modified on 5/29/2018 (nms). (Entered: 05/25/2018)
2018-05-25
1
[SEALED] REPLY BRIEF re 347 MOTION for Summary Judgment filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Certificate of Service)(Gattuso, Dominick) (Entered: 05/25/2018)
2018-05-25
1
[SEALED] DECLARATION of Dominick T. Gattuso re 368 Reply Brief, by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Exhibits 1-5, # 2 Certificate of Service)(Gattuso, Dominick) Modified on 5/29/2018 (nms). (Entered: 05/25/2018)
2018-05-25
1
Letter to The Honorable Richard G. Andrews, from Daniel M. Attaway, regarding CD containing hyperlinked documents. (Attaway, Daniel) Modified on 5/29/2018 (nms). (Entered: 05/25/2018)
2018-05-25
1
REQUEST for Oral Argument by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation re 347 MOTION for Summary Judgment . (Gattuso, Dominick) (Entered: 05/29/2018)
2018-05-29
1
REDACTED VERSION of 368 Reply Brief by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) (Entered: 05/31/2018)
2018-05-31
1
REDACTED VERSION of 369 Declaration of Dominick T. Gattuso, by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Attachments: # 1 Exhibits 1-5)(Gattuso, Dominick) Modified on 5/31/2018 (nms). (Entered: 05/31/2018)
2018-05-31
1
REQUEST for Oral Argument by Takeda Pharmaceuticals U.S.A., Inc. re 347 MOTION for Summary Judgment . (Attaway, Daniel) (Entered: 06/01/2018)
2018-06-01
1
NOTICE of Withdrawal of Pro Hac Attorney, Ilan Wurman by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation (Gattuso, Dominick) (Entered: 06/01/2018)
2018-06-01
1
STIPULATION Regarding Dismissal of "DDI Patents" by Takeda Pharmaceuticals U.S.A., Inc.. (Attaway, Daniel) (Entered: 06/04/2018)
2018-06-04
1
SO ORDERED Granting 376 Stipulation and Order to Dismiss "DDI Patents". Signed by Judge Richard G. Andrews on 6/4/2018. (nms) (Entered: 06/04/2018)
2018-06-04
1
CORRECTING ENTRY: The pdf for Exhibit 45 found at D.I. 363 has been replaced per counsel's request. Pages inadvertently omitted have been added to the filing. (nms)
2018-06-13
1
No Actions
Letter to The Honorable Richard G. Andrews, from Dominick T. Gattuso, enclosing USB Drive with Summary Judgment Briefing with Hyperlinks. (Gattuso, Dominick) Modified on 6/22/2018 (nms). (Entered: 06/22/2018)
2018-06-22
1
[SEALED] MEMORANDUM ORDER. Signed by Judge Sherry R. Fallon on 6/28/2018.This order has been emailed to local counsel. (nmf) (Entered: 06/28/2018)
2018-06-28
1
[SEALED] Letter to the Honorable Sherry R. Fallon from Daniel Attaway regarding Proposed Redacted Memorandum Order. (Attachments: # 1 Proposed Redacted Memorandum Order)(Attaway, Daniel) (Entered: 07/05/2018)
2018-07-05
1
REDACTED VERSION of 379 Memorandum Order. (lih) (Entered: 07/10/2018)
2018-07-10
1
NOTICE of Party Name Change of West-Ward Pharmaceuticals Corporation to Hikma Pharmaceuticals USA Inc. by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation (Gattuso, Dominick) (Entered: 07/10/2018)
2018-07-10
1
STIPULATION to Amend Case Caption by Hikma Americas Inc., Hikma Pharmaceuticals PLC, West-Ward Pharmaceutical Corporation. (Gattuso, Dominick) (Entered: 07/11/2018)
2018-07-11
1
[SEALED] OBJECTIONS by Takeda Pharmaceuticals U.S.A., Inc. to 379 Memorandum and Order . (Attaway, Daniel) (Entered: 07/12/2018)
2018-07-12
1
[SEALED] DECLARATION of Daniel M. Attaway re 384 Objections, by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit 1)(Attaway, Daniel) Modified on 7/17/2018 (nms). (Entered: 07/12/2018)
2018-07-12
1
REDACTED VERSION of 380 Letter by Takeda Pharmaceuticals U.S.A., Inc.. (Attaway, Daniel) (Entered: 07/17/2018)
2018-07-17
1
REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI # 380 . (nms)
2018-07-17
1
No Actions
REDACTED VERSION of 384 Objections by Takeda Pharmaceuticals U.S.A., Inc.. (Attaway, Daniel) (Entered: 07/18/2018)
2018-07-18
1
REDACTED VERSION of 385 Declaration by Takeda Pharmaceuticals U.S.A., Inc.. (Attaway, Daniel) (Entered: 07/18/2018)
2018-07-18
1
SO ORDERED, re 383 Stipulation to amend case caption. Signed by Judge Richard G. Andrews on 7/24/2018. (nms) (Entered: 07/24/2018)
2018-07-24
1
[SEALED] RESPONSE to 384 Objections, filed by Hikma Americas Inc., Hikma Pharmaceuticals PLC, Hikma Pharmaceuticals USA Inc..Reply Brief due date per Local Rules is 8/2/2018. (Attachments: # 1 Certificate of Service)(Gattuso, Dominick) Modified on 7/26/2018 (nms). (Entered: 07/26/2018)
2018-07-26
1
ORAL ORDER: A Telephone Status Conference is now set for 8/8/2018, at 3:00 PM before Judge Richard G. Andrews. The parties shall mutually coordinate the call to Chambers. Ordered by Judge Richard G. Andrews on 7/27/2018. (nms) (Entered: 07/27/2018)
2018-07-27
1
ORAL ORDER: There is no abuse of discretion in the Magistrate Judges Memorandum Order (D.I. 379 ), and the objections to it (D.I. 384 ) are OVERRULED. The Court will consider on August 8 during the status teleconference whether (if Takeda wishes) the parties should be allowed to rewrite and resubmit the briefs (with no extension of page limits) located at D.I. 339 and 354 . Ordered by Judge Richard G. Andrews on 7/30/2018. (nms) (Entered: 07/30/2018)
2018-07-30
1
REDACTED VERSION of 390 Answering Brief in Opposition, by Hikma Americas Inc., Hikma Pharmaceuticals PLC, Hikma Pharmaceuticals USA Inc.. (Gattuso, Dominick) (Entered: 08/01/2018)
2018-08-01
1
Minute Entry for proceedings held before Judge Richard G. Andrews - Status Conference held on 8/8/2018. (Court Reporter Leonard Dibbs.) (ksr, )
2018-08-08
1
No Actions
ORAL ORDER: A hearing on 323 MOTION for Recovery of Damages on Bond is set for 10/16/2018 at 10:00 AM in Courtroom 6A before Judge Richard G. Andrews. Ordered by Judge Richard G. Andrews on 8/9/2018. (ksr, ) (Entered: 08/09/2018)
2018-08-09
1
ORAL ORDER: A hearing on 347 MOTION for Summary Judgment is set for 10/16/2018 at 02:00 PM in Courtroom 6A before Judge Richard G. Andrews. Ordered by Judge Richard G. Andrews on 8/9/2018. (ksr, ) (Entered: 08/09/2018)
2018-08-09
1
Official Transcript of Status Conference held on 08-08-18 before Judge Richard G. Andrews. Court Reporter/Transcriber Leonard A. Dibbs. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 8/31/2018. Redacted Transcript Deadline set for 9/10/2018. Release of Transcript Restriction set for 11/8/2018. (lad) (Entered: 08/10/2018)
2018-08-10
1
NOTICE of Withdrawal of Appearance of Samuel S. Park by Hikma Americas Inc., Hikma Pharmaceuticals PLC, Hikma Pharmaceuticals USA Inc. (Gattuso, Dominick) (Entered: 08/24/2018)
2018-08-24
1
Minute Entry for proceedings held before Judge Richard G. Andrews - Oral Argument held on 10/16/2018. (Court Reporter Heather Triozzi.) (ksr, )
2018-10-16
1
No Actions
Minute Entry for proceedings held before Judge Richard G. Andrews - Oral Argument held on 10/18/2018. (Court Reporter Heather Triozzi.) (ksr, )
2018-10-18
1
No Actions
ORDER: The parties will submit a lost profits estimate to the Court by November 2, 2018 (see Order for further details). Signed by Judge Richard G. Andrews on 10/19/2018. (nms) (Entered: 10/19/2018)
2018-10-19
1
Letter to The Honorable Richard G. Andrews from Dominick T. Gattuso regarding Hikma's reply slides from the October 16, 2018 Bond Hearing. (Gattuso, Dominick) (Main Document 399 replaced on 10/25/2018) (nms). (Entered: 10/25/2018)
2018-10-25
1
CORRECTING ENTRY: The pdf for D.I. 399 has been replaced with a corrected version per counsel's request. The NEF for the filing will be regenerated. (nms)
2018-10-25
1
No Actions
[SEALED] Letter to The Honorable Richard G. Andrews, from Dominick T. Gattuso, regarding Hikma's Lost Profits Estimate. (Attachments: # 1 Exhibits 1-4)(Gattuso, Dominick) Modified on 11/5/2018 (nms). (Entered: 11/02/2018)
2018-11-02
1
[SEALED] Letter to Honorable Richard G. Andrews, from Daniel M. Attaway, regarding lost profit calculations. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Attaway, Daniel) Modified on 11/5/2018 (nms). (Entered: 11/02/2018)
2018-11-02
1
[SEALED] Letter to Honorable Richard G. Andrews from Daniel M. Attaway regarding Lost Profits Letter Brief. (Attachments: # 1 Exhibit A)(Attaway, Daniel) (Entered: 11/02/2018)
2018-11-02
1
ORDER: Plaintiff's Letter regarding the Bond Cap (D.I. 402) is stricken. Defendants are ordered to submit a response to Plaintiff's Letter regarding Lost Profits Letter Brief (D.I. 403 ) by November 9, 2018. Signed by Judge Richard G. Andrews on 11/5/2018. (nms) (Entered: 11/05/2018)
2018-11-05
1
CORRECTING ENTRY: D.I. 402 has been removed from the docket per the directive at D.I. 404 . (nms)
2018-11-05
1
No Actions
REDACTED VERSION of 400 Letter by Hikma Americas Inc., Hikma Pharmaceuticals PLC, Hikma Pharmaceuticals USA Inc.. (Attachments: # 1 Exhibit 1 - 4)(Gattuso, Dominick) (Entered: 11/09/2018)
2018-11-09
1
REDACTED VERSION of 401 Letter by Takeda Pharmaceuticals U.S.A., Inc.. (Attaway, Daniel) (Entered: 11/09/2018)
2018-11-09
1
REDACTED VERSION of 403 Letter by Takeda Pharmaceuticals U.S.A., Inc.. (Attaway, Daniel) (Entered: 11/09/2018)
2018-11-09
1
[SEALED] Letter to The Honorable Richard G. Andrews, from Dominick T. Gattuso, responding to Takeda's November 2 Letter (D.I. 403 ). (Attachments: # 1 Exhibits 5-8)(Gattuso, Dominick) Modified on 11/9/2018 (nms). (Entered: 11/09/2018)
2018-11-09
1
SEALED Official Transcript of Oral Argument Hearing held on 10/16/2018, before Judge Richard G. Andrews. Court Reporter/Transcriber Heather M. Triozzi,Telephone number 302-573-6195. (Triozzi, Heather) Modified on 12/11/2018 (nms). (Entered: 11/14/2018)
2018-11-14
1
Official Transcript of Oral Argument Hearing held on 10/16/2018 before Judge Richard G. Andrews. Court Reporter/Transcriber Heather M. Triozzi,Telephone number 302-573-6195. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 12/5/2018. Redacted Transcript Deadline set for 12/17/2018. Release of Transcript Restriction set for 2/12/2019. (Triozzi, Heather) (Entered: 11/14/2018)
2018-11-14
1
NOTICE of Intent to Request Redaction by Daniel Marcus Attaway. (Attaway, Daniel) Modified on 11/25/2018 (nms). (Entered: 11/21/2018)
2018-11-21
1
[SEALED] MOTION for Redaction of Transcripts - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Text of Proposed Order).(Attaway, Daniel) Modified on 12/6/2018 (nms). (Entered: 12/05/2018)
2018-12-05
1
Motions No Longer Referred: 412 MOTION for Redaction of Transcripts (nms)
2018-12-06
1
No Actions
ORDER: The Motion for Redaction of Transcripts (D.I. 412 ) is GRANTED IN PART. Signed by Judge Richard G. Andrews on 12/6/2018. (nms) (Entered: 12/07/2018)
2018-12-07
1
REDACTED VERSION of 409 Sealed Transcript. (nms) (Entered: 12/11/2018)
2018-12-11
1
MEMORANDUM OPINION. Signed by Judge Richard G. Andrews on 12/12/2018. (nms)
2018-12-12
1
ORDER: Defendants' Motion for Summary Judgment (D.I. 347 ) is GRANTED. Signed by Judge Richard G. Andrews on 12/12/2018. (nms) (Entered: 12/12/2018)
2018-12-12
1
REDACTED VERSION of 412 MOTION for Redaction of Transcripts by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Text of Proposed Order)(Bourke, Mary) (Entered: 12/12/2018)
2018-12-12
1
MEMORANDUM OPINION. Signed by Judge Richard G. Andrews on 12/12/2018. (nms)
2018-12-12
1
ORDER: The Motion to Recover Damages for Wrongful Restraint (D.I. 323 ) is GRANTED IN PART. Defendants are entitled to recover $31,407,800 in lost profits and pre-judgment interest during the period of the bond in the amount of $462,272.09. The Motion is DENIED IN PART as to incidental expenses and costs. Signed by Judge Richard G. Andrews on 12/12/2018. (nms) (Entered: 12/12/2018)
2018-12-12
1
JUDGMENT in favor of Hikma Americas Inc., Hikma Pharmaceuticals PLC, Hikma Pharmaceuticals USA Inc. against Takeda Pharmaceuticals U.S.A., Inc. (CASE CLOSED). Signed by Judge Richard G. Andrews on 12/12/2018. (nms) (Entered: 12/12/2018)
2018-12-12
1
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,964,647; US 7,964,648; US 7,981,938; US 8,097,655; US 8,440,722; US 7,619,004; US 8,093,297; US 8,415,395. (Attachments: # 1 Judgment)(nms) (Entered: 12/13/2018)
2018-12-13
1
[SEALED] STIPULATION and Order Regarding Hikma's Costs by Hikma Americas Inc., Hikma Pharmaceuticals PLC, Hikma Pharmaceuticals USA Inc.. (Gattuso, Dominick) (Entered: 01/25/2019)
2019-01-25
1
REDACTED VERSION of 422 Stipulation by Hikma Americas Inc., Hikma Pharmaceuticals PLC, Hikma Pharmaceuticals USA Inc.. (Gattuso, Dominick) (Entered: 01/25/2019)
2019-01-25
1
[SEALED] ORDER Granting 422 Stipulation and Order. Signed by Judge Richard G. Andrews on 1/25/2019.This order has been emailed to local counsel. (nms) (Entered: 01/28/2019)
2019-01-28
1
STIPULATION and Order Regarding Satisfaction of Judgment and Exoneration of Bond by Takeda Pharmaceuticals U.S.A., Inc.. (Attaway, Daniel) (Entered: 02/28/2019)
2019-02-28
1
SO ORDERED Granting 425 Stipulation and Order Regarding Satisfaction of Judgment and Exoneration of Bond. Signed by Judge Richard G. Andrews on 2/28/2019. (nms) (Entered: 03/01/2019)
2019-03-01
1